Archives: InvestorWire

July 5, 2024 13:57:18

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused institutional investors. The agreements, which are for the purchase and sale of 1,425,000 shares of common stock, are comprised of a registered direct offering and warrants. The offering and warrants are to purchase up to 1,425,000 shares of common stock in a concurrent private placement at a combined purchase price of $1.39 per share. The offering is expected to close today, subject to customary closing conditions, with gross proceeds estimated to reach about $1.98 million before deductions and expenses. CNS Pharmaceuticals plans to use the funds from the offering for working capital and general corporate purposes.

To view the full press release, visit https://ibn.fm/TYSIm

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anticancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information about the company, please visit www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Post-Conference Recap of the 4th PRC Performance Optimization Summit

July 5, 2024 09:35:00

The 4th PRC Performance Optimization Summit, held on June 5-6, 2024, in Philadelphia, gathered industry leaders to discuss optimizing promotional review committees (“PRC”). The summit featured sessions on compliance strategies, incorporating AI in PRC operations, and managing content updates for various digital platforms. Attendees benefited from expert presentations, interactive workshops, and networking opportunities aimed at enhancing PRC effectiveness and teamwork. Key discussions included ensuring compliance, preparing for modular content updates, and shaping review strategies for emerging technologies like virtual reality and mobile applications.

The summit provided a comprehensive overview of best practices for promotional review processes, focusing on real-world applications and practical solutions for common challenges faced by PRCs. Speakers joined from organizations including AbbVie, Biogen, Moderna, and Otsuka.

For those unable to attend in person, the summit offers an On-Demand option, allowing participants to watch the conference sessions at their convenience from anywhere. This ensures broader accessibility and the opportunity to benefit from the insights shared during the event.

Watch On-Demand: https://dgevents.com/event/prc-performance_optimization-summit/

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Laredo Oil Inc. (LRDC), Subsidiary Announce Oil Shows as Drilling Depth Met at First of Three Midfork Production Wells

July 5, 2024 08:47:00

Laredo Oil (OTC: LRDC), an oil exploration and production company, and its wholly owned subsidiary, Hell Creek Crude (“HCC”) LLC, are reporting oil shows in three zones of the Reddig 11-21 well in the Midfork field located in Valley County, Montana. The oil shows were discovered as total drilling depth was met in drilling operated by HCC in the Midfork field. The Reddig 11-21 well is the first of three production wells HCC plans to drill and operate. “We are elated with our progress and expect to have the well ready for production in three to four weeks,” said Laredo Oil chair and CEO Mark See in the press release. “Once the well is producing, we will begin planning the next two wells we expect to drill and operate in the Midfork field.”

To view the full press release, visit https://ibn.fm/IWi7j

About Laredo Oil Inc.

Laredo Oil is an oil exploration and production company primarily engaged in acquisition and exploration efforts for mineral properties. In addition to pursuing conventional oil-recovery methods in selected oil fields, Laredo Oil plans to locate and acquire mature oil fields, with the intention of recovering “stranded” oil using enhanced recovery methods. For more information about the company, visit www.Laredo-Oil.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/LRDC

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces Plans to Begin 2024 Development Program

July 5, 2024 08:40:33

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a publicly traded energy company based in western Canada and specializing in the exploration, development and production of crude oil and natural gas, will be starting its 2024 development drilling program later this month. According to the announcement, the initial focus will be on multiped, medium-oil infill directional wells, based on 2023 positive drilling results. The program will be financed through nondilutive debt financing of $11 million, which was recently finalized and specifically dedicated to the 2024 development program. The company noted that the 2023 capital outlay for the initial medium-oil well is on target to pay out in approximately seven months demonstrating effective program execution and efficient return on capital. “Due to existing infrastructure already in place, these subsequent infill medium-oil wells are expected to continue robust economics,” stated the company in the press release. “The 2024 medium-oil drilling program includes infill development of two pools and the initial drilling of a new pool. The horizontal transformation to capture the substantial remaining heavy oil reserves will be continued subsequent to the medium-oil drills. Multilateral development is also proposed for the untapped other two core heavy oil properties. In addition to the improved recovery via horizontal wells and reservoir management, enhanced oil recovery is commencing with a pilot project.”

To view the full press release, visit https://ibn.fm/zPAjx

About Prospera Energy Inc.

Prospera Energy is a publicly traded energy company based in western Canada, specializing in the exploration, development and production of crude oil and natural gas. Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir-development methods and production practices. Prospera was restructured in the first quarter of 2021 to become profitable and in compliance with regulatory, environmental, municipal, landowner and service stakeholders. The company is in the midst of a three-stage restructuring process aimed at prioritizing cost-effective operations while appreciating production capacity and reducing liabilities. Prospera has completed the first phase by optimizing low-hanging opportunities and attaining free cash flow while also bringing operations to safe operating condition and remaining compliant. Currently, Prospera is executing phase 2 of the restructuring process, the horizontal transformation intended to accelerate growth and capture the significant remaining reserves (400 million bbls). These horizontal wells allow PEI to reduce its environmental and surface footprint by eliminating the numerous vertical well leases along the lateral path. Phase 3 of Prospera’s corporate redevelopment strategy is to optimize recovery through EOR applications. Prospera will also pursue its acquisition strategy to diversify its product mix and expand its core area. Its goal is to attain 50% light oil, 40% heavy oil and 10% gas. PEI continues to apply efforts to minimize its environmental footprint as well as efforts to reduce and eventually eliminate emissions while also pursuing innovative ESG methods to enhance API quality, thereby achieving higher margins and eliminating the need for diluents. For more information, visit the company’s website at www.ProsperaEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to GXRFF are available in the company’s newsroom at https://ibn.fm/GXRFF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

WTO Report Says Trade Aid Could Broaden Opportunities in Energy Transition

July 5, 2024 08:05:00

The World Trade Organization Secretariat report has revealed that trade aid will be vital to broadening opportunities in the global transition to green energy. Launched late last month at the Global Review of Aid for Trade, the report noted that least-developed countries (LDCs) as well as developing economies have access to significant trade opportunities as the world transitions to renewables. It also outlined the role finance will play in helping such nations leverage available trade opportunities in the clean-energy-related product and service value chain.

The “Aid for Trade in Action: Supporting the Transition to Clean Energy” report acknowledged that countries are adopting clean energy at accelerating rates, bringing the share of global electricity produced by solar, wind, hydrogen, nuclear and hydropower now generated to nearly 40%. Experts predict that the share of clean energy will continue to rise even faster as renewables become cheaper and countries ramp up green-energy adoption to meet national and global carbon-emission goals.

According to the report, the green-energy transition provides numerous opportunities for least-developed countries and developing economies to increase their trade volume and diversify their exports. It noted that Aid for Trade has already started offering financial support for the transition to clean energy, channeling 30% of all its climate objective commitments ($60 billion) from 2011 to 2021 into the energy sector. Despite the magnitude of this investment, it still isn’t enough to make an impact in terms of overall climate finance flows.

Less than one-fifth of clean-energy investments go to LDCs and developing economies, limiting their ability to effectively leverage trade opportunities. As per the report, developing economies and LDCs could increase their participation in global trade through three key segments: minerals and metals, services, and machinery and equipment manufacturing. The report also outlined different carbon-credit-related development opportunities as well as the potential benefits of using carbon capture and storage systems to reduce emissions from current exports.

LDCs and developing economies with natural resources could use financial aid to develop sustainable extraction facilities and attract foreign investment. Investing in the clean-equipment manufacture segment also offers a potentially rewarding financial opportunity as the segment is projected to surpass $1 trillion by the middle of the century, while a robust clea- energy-related services sector could help increase the odds for cross-border trade, increase growth opportunities and create new employment opportunities. Forward-thinking economies could use these opportunities to develop themselves into manufacturing value chain hubs over the next several decades.

In the more developed economies of the west, enterprises such as FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) are positioning themselves to reap the benefits of providing alternative energy solutions to meet the growing need for clean energy.

NOTE TO INVESTORS: The latest news and updates relating to FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) are available in the company’s newsroom at https://ibn.fm/NHHHF

About GreenEnergyStocks

GreenEnergyStocks (“GES”) is a specialized communications platform with a focus on companies working to shape the future of the green economy. GreenEnergyStocks is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GES is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, GES brings its clients unparalleled recognition and brand awareness. GES is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

Could NIO Inc Shares Be Poised for Major Climb?

July 5, 2024 08:05:00

The electric vehicle (EV) market is facing an upward trajectory after a rough patch, suggesting renewed confidence and optimism, which is particularly beneficial for investors in the industry. Global sales of electric vehicles have hit 14 million, raising the total number of these vehicles on the road to 40 million.

One of the companies reaping rewards is Rivian. The company has witnessed a recent surge fueled by a massive $5 billion investment from Volkswagen. Following this example, NIO stock price jumped by 8.07% in the week that has just ended.

The recent surge in stock price has helped NIO Inc. (NYSE: NIO) reduce its price decline to 46.14%, a significant improvement from the steep decline experienced earlier this year. Nevertheless, some indicators have given a quite different perspective on this matter for NIO stock. It has shown a persistent downward trend over the medium- to long-term, indicating waning investor interest.

The Chinese luxury electric vehicle maker stock is in a support range of $4.29–$4.33 and a resistance zone of $4.65–$4.73. These trends are the result of many trend lines, and key moving averages within various time horizons provide the limits. A breakout from either of these could signal the start of significant future recurrent moves.

The relative strength index (RSI) for NIO stock has been advancing upward, rising from 30 to 48.07, indicating the stock is moving out of oversold territory and suggesting a potential price increase. Furthermore, NIO forms a symmetrical triangle pattern on the daily chart, often preceding significant price movements.

Despite these positive changes, the company’s stock price is still below the 20, 100 and 200 simple moving averages (SMA), which is considered bearish. The good thing, however, is that the stock is now trading above its 5 and 10 SMAs, indicating an upward momentum that may be possible soon.

As this industry continues to gain momentum, NIO is poised to capitalize on this growth and deliver substantial returns for investors. Even though the technical indicators are still mixed, the company’s recent upward trajectory and Rivian’s success have sparked hope for investors that NIO is poised for a major climb.

The global EV market is expected to grow, with key manufacturers expected to sell more than 20 million vehicles by 2030. This would lead to EV makers making up to 58% of car sales, supporting the current forecasts.

About BillionDollarClub

BillionDollarClub (“BDC”) is a specialized communications platform with a focus on the biggest and brightest companies covered by IBN. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BDC is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, BDC brings its clients unparalleled recognition and brand awareness.

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

Please see full terms of use and disclaimers on the BillionDollarClub website applicable to all content provided by BDC, wherever published or re-published: https://www.BillionDollarClub.com/Disclaimer

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatmentw

July 5, 2024 08:05:00

Clene revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado
The only current FDA-approved drug for Rett Syndrome is trofinetide, approved in 2023
CNM-Au8 treatment showed improvements in mitochondrial respiration deficits in Rett patient-derived astrocytes

Clene (NASDAQ: CLNN), along with its subsidiary Clene Nanomedicine Inc., a biopharmaceutical company specializing in mitochondrial health to address neurological diseases like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment. The data was presented by Dr. Karen Ho, Clene’s Vice President of Translational Medicine, at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado. The presentation, titled “CNM-Au8, a Candidate First-in-Class Nanotherapeutic for Treatment of Rett Syndrome,” highlighted CNM-Au8’s potential (https://ibn.fm/NAtz7).

Rett Syndrome is a severe and rare pediatric neurological disorder caused by mutations in the MECP2 gene on the X chromosome. It predominantly affects females, occurring in about 1 in 10,000 live female births. Children with MECP2 mutations develop normally for the first six months of life but then experience a regression in skills, leading to various neurological and developmental issues such as loss of hand movement, abnormal gait, respiratory problems, autism spectrum traits, motor dysfunction, loss of verbal skills, seizures, and Parkinson-like features. The disorder also involves microcephaly and myelin loss in the brain. Currently, the only FDA-approved drug for Rett Syndrome is trofinetide, approved in 2023.

CNM-Au8 is an oral nanotherapeutic that enhances energy metabolism in nervous system cells, including neurons and oligodendrocytes, to support neuronal survival and remyelination. Clene has primarily been developing CNM-Au8 for ALS and MS, but its unique mechanism of action has led to considering its potential for treating Rett Syndrome.

The research, conducted in collaboration with Dr. Kathrin Meyer, formerly of Nationwide Children’s Hospital and now Chief Scientific Officer of Alcyone Therapeutics, along with her former postdoctoral researchers Drs. Meysam Ganjibakhsh and Andrea Sierra Delgado, explored the impact of CNM-Au8 on Rett Syndrome. Dr. Delgado is now a Research Assistant Professor at the University of Missouri.

Key preliminary findings include significant improvements in neuronal health (p<0.01), neuron survival (p<0.0001), and neurite lengths (p<0.05) in an in vitro model of Rett Syndrome.

Additionally, CNM-Au8 treatment showed improvements in mitochondrial respiration deficits in Rett patient-derived astrocytes, with full rescue (p<0.0001) of both basal and ATP-linked respiration in one Rett line and partial rescue (p<0.001 improvement in ATP-linked respiration) in another.

Dr. Ho said Rett Syndrome has a disease mechanism that shares some common features with both ALS and MS, with dysfunctional energy metabolism, glutamate excitotoxicity, demyelination, and mitochondrial dysfunction being hallmarks of the challenges faced by the nervous system in all three of these diseases.

“These preliminary data suggest that CNM-Au8 may treat Rett syndrome by potential rescue of mitochondrial dysfunction, thereby promoting neuronal health, survival, and synaptic structure. If CNM-Au8 proves to be a successful treatment for Rett syndrome, this will add further affirmation to Clene’s central thesis: that CNM-Au8—with its versatile and unique catalytic mechanism—holds promise as a potential treatment for multiple diseases of the nervous system, beyond its current targets of ALS and MS,” Dr. Ho added.

The study received support from the Baby Eleanor Foundation, and the team acknowledged the donation of Rett and healthy control cells from anonymous individuals. Dr. Ho emphasized the potential impact of CNM-Au8 on millions of people with difficult-to-treat neurological diseases, highlighting the rewarding nature of their ongoing research. “It’s a truly rewarding time to participate in the development of CNM-Au8, which has strong potential to make a difference to the millions of people living with difficult-to-treat neurologic diseases,” she said.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Sustainable Green Team Ltd. (SGTM) CEO Spotlighted on Upcoming New to The Street Episode Airing July 4

July 3, 2024

July 3, 2024 09:42:14

Sustainable Green Team (OTCQX: SGTM), a leading provider of sustainable agricultural solutions, is spotlighted on FMW Media’s upcoming New to The Street TV episode. According to the announcement, episode 579 will be broadcast on Bloomberg TV on July 4, 2024, at 9:30 p.m. ET. The episode includes five interviews, including one with Sustainable Green Team CEO and founder Tony Raynor. During the segment, Raynor and host Jane King discuss how agricultural companies are able to meet their sustainability goals using SGTM’s products and services. Raynor noted that the company offers groundbreaking technologies supported by a global team of experts and consultants with expertise in finance, government agencies and sustainability methodologies. “The adage, ‘Wisdom comes through the multitude of counsel’ explains Tony’s team of global personnel committed to spearheading projects with the vision for immediate objectives and sustainable solutions,” stated the press release. “With personnel in the Middle East, Australia and the USA, Tony has the right team to launch all SGTM’s products and services globally. SGTM’s technology converts waste into nutrient-rich soil, diminishing food insecurities while sequestering carbon, reducing odors, and limiting diseases.”

To view the full press release, visit https://ibn.fm/tZ2jF

About Sustainable Green Team Ltd.

Sustainable Green Team is a leading company in climate-reversing technologies, a provider of sustainable solutions to improve environmental health, promote sustainable practices and deliver ecofriendly products and services. SGTM aims to make significant contributions to global sustainability. For more information about the company, please visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI Holdings Inc. (ECGI) and Pacific Saddlery to Launch New Line of Ready-to-Wear Equestrian Apparel Targeting Burgeoning Market

July 3, 2024

July 3, 2024 08:50:00

ECGI Holdings and Pacific Saddlery are gearing up to launch a new line of ready-to-wear equestrian apparel under Pacific Saddlery’s celebrated Allon brand
This launch follows the June 13 announcement that ECGI had signed a binding Letter of Intent (“LOI”) to acquire all outstanding shares of Pacific Saddlery
The launch is aimed at catering to the growing demand for high-quality equestrian apparel and tapping into the expected growth in the overall global equestrian market
Pacific Saddlery is expected to showcase Pacific Saddlery’s Allon collection at the American Equestrian Trade Association (“AETA”) International trade show in August

Earlier in June, ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio of viticulture, hospitality, and luxury fashion, signed a binding Letter of Intent (“LOI”) to acquire all outstanding shares of Pacific Saddlery Inc., a renowned manufacturer and retailer of luxury equestrian tack, apparel, and accessories. The partnership is expected to elevate Pacific Saddlery’s brand and expand its presence in the luxury equestrian marketplace (https://ibn.fm/3q0rq).

“Our shared vision and combined resources will create unique and memorable products for our customers,” Nick Collins, the president of Pacific Saddlery and a well-known professional in the equestrian luxury market, said of the partnership. This shared vision and the combined resources are already…

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Nightfood Holdings Inc. (NGTF) Eyes Growth Through Robotics and Sleep-Friendly Snacks

July 3, 2024

July 3, 2024 08:05:00

Restaurants services are facing growing pressure for efficiency, which can be accomplished by the integration of robotics into daily performance
Nightfood Holdings has acquired Future Hospitality Ventures Holdings, an emerging leader in Robots-as-a-Service for restaurants, subsequently appointing Sonny Wang as CEO of NGTF to lead expansion and growth

Nightfood Holdings (OTCQB: NGTF), a previously under-the-radar holding company focused on acquisitions in the hospitality, food service, and CPG sectors, has announced a two-pronged strategic move. This initiative targets both the operational efficiency of the hospitality sector and the growing consumer demand for sleep-focused wellness products. While seemingly disparate on the surface, a closer examination reveals a potentially synergistic approach with the potential to unlock significant shareholder value.

The recent acquisition of Future Hospitality Ventures Holdings, Inc., a California-based robotics company focused on Robots-as-a-Service (“RaaS”), positions Nightfood at the forefront of automation solutions for the food service industry. This move comes at a critical time, as rising minimum wages put pressure on…

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Golden Triangle Ventures Inc.’s (GTVH) Lavish Moves to Become Staple in the Entertainment Industry

July 1, 2024

July 1, 2024 14:54:50

Golden Triangle Ventures’ (OTC: GTVH) Lavish Entertainment embodies GTVH’s focus on vertical integration to cut costs and maximize margins, as evidenced by its recently released four-pillar business model. “According to GTVH, this strategic framework provides an essential piece of Lavish’s mission to create an industry leading entertainment business. The company’s new model includes key foundational elements – logistics, staffing, equipment and production – that were carefully identified and organized to complement each other and ensure seamless operations across all facets of the company. With its new business model as a backdrop, Lavish Entertainment plans to develop and acquire operations in each of the four areas of the plan,” a recent article reads. “We are thrilled to introduce our innovative four-pillar business model, which represents a bold step forward in our journey to develop Lavish into a staple in the entertainment industry,” said Marco Antonio Moreno, president and COO of Lavish Entertainment. “We look forward to showing our shareholders how this new business model will unfold.”

To view the full article, visit https://ibn.fm/hSfMm

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors, along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors in which this company aims to do business. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help the company grow daily. Being a publicly traded company gives the ability to provide the support needed to help each subsidiary grow into the business that management believes it can and will become. For more information, visit the company’s website at www.GoldenTriangl e Inc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreak – RYVYL Inc. (NASDAQ: RVYL) Increases Focus on Diversifying into New Vertical Markets

July 1, 2024

July 1, 2024 09:48:00

RYVYL (NASDAQ: RVYL) is a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for diverse international markets. The company announced that it has aligned its U.S. operations to increase its focus on diversifying into new vertical markets within its Northeast Merchant Systems (“NEMS”) business unit. In addition to leading its licensing strategy, RYVYL’s VP of Revenue Christian Murray was promoted to a newly created position of managing director of NEMS effective July 15, 2024. “RYVYL has developed visionary technology to verify, secure and record payment transactions that has been enthusiastically received by merchants and end customers, despite recent changes in the regulatory environment that impacted our U.S. segment revenue in the past six months. To increase monetization of our technology, we have been focusing U.S. operations on diversifying vertical markets and leveraging software licensing to expand our market penetration,” said Fredi Nisan, co-founder, director and CEO of RYVYL. “In March 2024, we began streamlining operations, including outsourcing payment logistics to third-party partners and reducing approximately 25% of U.S.-based positions. These efforts are improving efficiencies, freeing up resources to reinvest in key growth areas, creating a more agile organization and positioning us to capture a growing pipeline of diversified opportunities within our NEMS business unit as well as to address changes within the fintech compliance landscape to deliver exceptional value and ensure strong positioning within the market.”

To view the full press release, visit https://ibn.fm/H4ktI

About RYVYL Inc.

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business, and peer-to-peer payment transactions around the globe. By leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, RYVYL is a leading innovator of payment transaction solutions reinventing the future of financial transactions. Since its founding as GreenBox POS in 2017 in San Diego, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection, and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information, visit RYVYL’s website at www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreak – Siyata Mobile Inc. (NASDAQ: SYTA) Closes on Estimated $6M Public Offering

July 1, 2024

July 1, 2024 08:33:00

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of Push-to-Talk over Cellular (“PoC”) handsets and accessories, has closed on its previously announced public offering. The offering was comprised of about $6 million of common shares as well as prefunded warrants to purchase common shares at $0.58 per share. According to the announcement, funds from the offering do not include any proceeds from the future exercise of the prefunded warrants issued in the offering. Siyata Mobile anticipates using the monies from the public offering for a variety of reasons, including working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, and possible future acquisitions. Dominari Securities LLC acted as the sole placement agent in connection with the offering.

To view the full press release, visit https://ibn.fm/kh2Eq

About Siyata Mobile Inc.

Siyata Mobile is a business-to-business (“B2B”) global developer and vendor of next-generation, Push-to-Talk (“PTT”) over Cellular (“POC”) handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste-management companies, resorts and many other organizations use Siyata PTT handsets and accessories. In support of its Push-to-Talk handsets and accessories, Siyata also offers enterprise-grade, in-vehicle solutions and cellular booster systems enabling customers to communicate effectively when they are in their vehicles, even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Granted Sports Betting, iGaming License in Peru

June 28, 2024 12:05:00

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, has been awarded a sports betting and iGaming license in Peru by the Ministry of Foreign Trade and Tourism of Peru. The license was issued to Meridian Gaming Peru S.A.C., a subsidiary of MeridianBet Group, a business-to-business (“B2B”) and business-to-consumer (“B2C”) sports betting and iGaming provider that Golden Matrix acquired earlier this year. The online sports betting and iGaming market gaming industry in Peru is estimated to be $1.2 billion with annual growth projected at 6.4% through 2028. Golden Matrix also recently received a sports-betting license in South Africa; the new licenses solidify GMGI’s strategic expansion into high-growth markets. “We are thrilled to enter the Peruvian market, a region poised for massive growth and unprecedented expansion in the coming years,” said MeridianBet Group CEO Zoran Milosevic in the press release. “This market entry presents an exciting opportunity to further grow our user base and deliver additional value to shareholders, underscoring our ongoing commitment to developing industry-leading brands globally.”

To view the full press release, visit https://ibn.fm/dSwoF

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is a leading business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company utilizing proprietary technology and operating globally across multiple international markets. The B2B division of Golden Matrix develops and licenses branded gaming platforms for its extensive list of clients. Its B2C division, RKings, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company also owns and operates MEXPLAY, a regulated online casino in Mexico. In 2024, Golden Matrix completed the acquisition of MeridianBet, a well-established B2B and B2C sports betting and gaming platform operating and regulated in multiple markets in Europe, Africa and Latin America, providing the combined entity with additional international operations. For more information about the company, visit www.GoldenMatrix.com.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – DigiAsia Corp. (NASDAQ: FAAS) Closes on $3.6M Private Placement

June 28, 2024 10:02:22

DigiAsia (NASDAQ: FAAS), a leading Fintech as a Service (“FaaS”) ecosystem provider, has entered into a Securities Purchase Agreement (“SPA”) with a group of investors. According to the agreement, DigiAsia will sell certain Class A convertible promissory notes and Class B convertible promissory notes as well as warrants. The notes, which have a one-year maturity, total up to $8,863,528.24. Each warrant will be a five-year warrant for a number of ordinary shares equal to the principal amount of the Class A note issued to the applicable investor, multiplied by 60% and divided by 120% of the closing price of the ordinary shares on the trading day immediately preceding the issue of the applicable warrant. EF Hutton served as placement agent for the private placement.

To view additional information, visit https://ibn.fm/YALzy

About DigiAsia Corp.

DigiAsia aims to enable financial transactions across all customer segments by supporting every aspect of partners’ financial transformation to the digital era with low-cost, mass-market diverse financial products. DigiAsia’s strategy is to acquire and operationally consolidate digital, traditional distribution and logistics ecosystems through low-cost payment rails using an embedded finance approach. DigiAsia offers its financial services, including closed and open loop wallets, QR payments, cash-based and digital remittances, merchant-operated ATM/branch banking functionality and card issuance through a set of open-access APIs; these services can be consumed in the mobile app and web interface of partner customers. Rather than invest precious financial capital, time and human resources, DigiAsia partner customers have their branded or white-label fintech services live and operational within weeks. For more information about the company, please visit www.DigiAsia.asia.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award

June 28, 2024 09:57:12

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced that the United States District Court for the Eastern District of Pennsylvania ruled in favor of FSD Pharma and is granted its motion for entry of judgment against Dr. Raza Bokhari, the company’s former CEO. The decision awards FSD Pharma several awards, including $147,301.04 plus interest at a rate of 4% per annum from Nov. 9, 2022, until the date the judgment is satisfied; C$31,912.55 plus interest at a rate of 4% per annum from Nov. 9, 2022, until the date the judgment is satisfied; C$15,000 plus interest at a rate of 4% per annum from March 1, 2023, until the date the judgment is satisfied; and C$2,814,229.15 plus interest at a rate of 6% per annum from May 7, 2023, until the date the judgment is satisfied. The judgment results from action taken by Bokhari after FSD’s board of directors terminated him. “After years of litigation and an eight-day evidentiary hearing, the arbitrator ruled against Dr. Raza Bokhari and issued three awards against Dr. Raza Bokhari in favor of FSD, including an award for damages and awards for FSD’s fees and costs incurred in the arbitration,” stated the press release. “FSD will pursue all means possible to collect from Dr. Raza Bokhari, current chairman and CEO of Medicus Pharma Ltd.”

To view the full order, view https://ibn.fm/u0yvx

To view the full press release, visit https://ibn.fm/8LHO4

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown in preclinical models to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. FSD Pharma invented unbuzzd(TM) and spun out its OTC version to Celly Nutrition, a company led by industry veterans. FSD retains ownership of 25.71% of Celly Nutrition Corp. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax loss carry forward of approximately C$130 million and could be utilized in the future to offset tax payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical/medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit www.FSDPharma.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RECAP: Inaugural ARTIFICIAL INTELLIGENCE for Life Sciences Compliance Congress

June 28, 2024 09:35:00

The “Artificial Intelligence for Life Sciences Compliance Congress,” held on June 3-4, 2024, in Philadelphia, brought together industry leaders, compliance professionals, and regulatory experts to discuss the integration of AI in life sciences. The event emphasized modernizing risk management, data privacy, and analytics to meet evolving compliance standards. Keynote speakers and panelists provided insights into the challenges and opportunities of implementing AI technologies, focusing on regulatory adherence and innovative solutions.

The congress featured a series of in-depth sessions covering topics such as AI-driven compliance monitoring, ethical considerations in AI deployment, and strategies for ensuring data integrity and security. Attendees had the opportunity to engage in interactive workshops, network with peers, and…

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces $1M Private Placement by Company President Through Family Fund

June 28, 2024 08:58:23

Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, has announced a private placement. According to the announcement, Safety Shot president Jordan Schur, through his family investment group, Core 4 Capital Corp., has invested in a $1 million private placement in the company. This $1 million investment follows a $5 million investment that closed in April; that private placement also came from Core 4 Capital Corp. The $1 million in gross process resulted from the company issuing 943,396 shares at $1.06 per share. The company noted that no warrants were attached to the offering and no financing commissions were paid. “I’ve seen promise in this company from the very beginning, and I’m excited about the progress that I’ve seen over the last four months,” said Safety Shot president Jordan Schur in the press release. “Safety Shot’s growth trajectory is a testament to the innovation of our product and the demand for this type of solution in the market, and I can’t see a better use of my family’s funds than to help the continued advancement of the company in these early stages.”

To view the full press release, visit https://ibn.fm/ZMuHb

About Safety Shot Inc.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Stock Sees Uptick Following SEC Approval

June 28, 2024 08:53:31

Trump Media & Technology Group (NASDAQ: DJT) has recently seen a notable uptick in its stock value, marking a 23% increase that has helped recover some of its earlier losses. This surge is directly tied to the SEC’s green light for the company to register more shares, a move that not only allows early investors to sell off some of their holdings but also to act on stock warrants. These warrants let investors buy more shares at a set price before a certain date. With this approval, Trump Media is set to gain nearly $70 million from these transactions.

The company, which is behind the social media platform Truth Social, favored by former President Donald Trump, has had a rollercoaster year. Since completing a merger with a special purpose acquisition company (“SPAC”) in March, DJT’s stock has jumped an impressive 93% year-to-date. However, this growth hasn’t been without its challenges. The company reported a significant net loss of $327.6 million against modest revenue of $770,500 in its latest quarterly earnings. Despite these financial hurdles, Trump Media’s market valuation hovers around $6 billion, a figure buoyed by Trump’s own popularity and his substantial ownership stake in the company.

Currently, DJT’s stock is trading at $38.16, after a slight dip of 2.78%. This fluctuation is part of the broader volatility the stock has experienced, with its price swinging from a low of $12.51 to a high of $79.38 over the year. The company’s market capitalization now stands at approximately $6.74 billion, with around 6.9 million shares changing hands. This level of activity underscores the market’s keen interest in Trump Media, despite the company’s financial losses and the controversies surrounding its figurehead.

Trump Media’s journey has been further complicated by legal challenges faced by Donald Trump, including a recent conviction on multiple felony counts. However, Trump’s continued influence, particularly as he remains a prominent figure in the Republican Party, suggests that the company’s fortunes are closely tied to his political and social endeavors. This connection is evident in Trump Media’s strategic moves, including Trump’s foray into platforms like TikTok to boost engagement.

In summary, Trump Media’s stock performance and market valuation reflect a complex interplay of regulatory approvals, financial results, and the personal brand of its most notable shareholder. Despite facing significant financial losses and legal challenges, the company’s strategic initiatives and the enduring popularity of its main platform, Truth Social, continue to drive investor interest and market speculation.

To view the full press release, visit https://ibn.fm/XOOMp

About Trump Media & Technology Group Corp.

The mission of Trump Media & Technology Group Corp. is to end Big Tech’s assault on free speech by opening up the Internet and giving people their voices back. Trump Media & Technology Group operates Truth Social, a social media platform established as a safe harbor for free expression amid increasingly harsh censorship by Big Tech corporations. For more information, visit the company’s website at www.TMTGCorp.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Signs New Orders for Hemisphere ASR Deployment, K1 Blue Light Emergency Phone

June 27, 2024 13:00:00

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has announced the deployment of four of its proprietary K1 Hemisphere Autonomous Security Robots (“ASRs”). The company has also signed a new contract for it K1 Blue Light Emergency Phone.

According to the announcement, a Georgia-based online retailer has ordered the services of the Hemisphere ASRs. The robots will be patrolling four U.S. warehouses that contain more than 40,000 genuine, brand name fragrances, skincare, makeup, haircare, aromatherapy and candles. Two Hemispheres were deployed to the company’s Atlanta, Georgia facility, with another two Hemispheres deployed to its Pompano Beach, Florida, location. The Hemispheres help ensure employee safety while also discouraging theft and criminal trespassing.

“The Hemispheres are ideally suited for securing areas where the mobility of Knightscope’s K5 Autonomous Security Robots is not required,” stated the company in the press release. “In addition to the loading docks, the four machines are positioned to enable the monitoring of driveways leading into each property.”

Knightscope also announced that a full-service marina on one of Texas’ well-known lakes has finalized the purchase of its first K1 Blue Light E-phone. These devices are designed to elevate guest safety and complement the marina’s extensive recreational amenities and convenient services in a location widely recognizes for its hospitality and care.

“The familiar blue illuminated e-phones are a very reassuring sight when help or emergency services are needed alongside the waterway,” stated the company in the press release. “They work day and night in all weather and even when communications are most congested. Blue light emergency phone systems also always report one’s precise location reliably, ensuring the expedited arrival of the appropriate type of assistance.”

To view the full press release, visit https://ibn.fm/c5ihA

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Strengthens Financial Position with $15M Financing Transactions

June 27, 2024 12:40:00

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, today announced the successful restructuring of $8 million of its debt. The debt was due this month. The company also stated that it has secured an additional $2 million in debt financing. Additionally, key shareholders have exercised warrants at an exercise price of $0.90 per share, resulting in an additional $5 million in capital. The company expects these financing transactions to help it further enhance its product offerings, advance its Secure Data Fabric (“SDF”) roadmap, and drive forward growth in the cybersecurity space. “We are thrilled to have successfully completed these financial initiatives,” commented Noah Hershcovíz, CEO of Hub Security. “The refinancing of our debt, along with the additional debt financing and capital raised through the exercise of warrants, testifies to our investors’ confidence in our vision and strategic direction. Our strengthened financial position allows us to continue to fulfill our commitment to delivering state-of-the-art solutions to our clients.”

To view the full press release, visit https://ibn.fm/ZTUrn

About HUB Security Ltd.

HUB Cyber Security (“HUB Security”) was established in 2017 by veterans of the elite intelligence units of the Israeli Defense Forces. The company specializes in unique cybersecurity solutions protecting sensitive commercial and government information. The company debuted an advanced encrypted computing solution to prevent hostile intrusions at the hardware level while introducing a novel set of data theft prevention solutions. HUB Security operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide. For further information or inquiries, contact [email protected].

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Sets Pricing of Approximately $6M Public Offering

June 27, 2024 12:20:00

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, has announced the pricing of a public offering of approximately $6 million of common shares and/or pre-funded warrants to purchase common shares. The company has set a public offering price of $0.58 per unit (minus $0.01 per pre-funded warrant). Siyata Mobile plans to use the proceeds of the offering for working capital, general corporate purposes, payments to third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisitions, if any. The company expects the offering to close on June 28, 2024, subject to customary closing conditions. Dominari Securities LLC is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/FgZFe

About Siyata Mobile Inc.

Siyata Mobile is a B2B global developer and vendor of next-generation push-to-talk (“PTT”) over cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today. In support of its PTT handsets and accessories, Siyata also offers enterprise-grade in-vehicle solutions and cellular booster systems enabling customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit www.Siyata.net and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor

June 27, 2024 10:57:37

Vistagen (NASDAQ: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that it has been recognized by Mental Health America (“MHA”) for its dedication to promoting mental health and well-being in the workplace. This marks the second consecutive year the company has received this recognition. According to the announcement, Vistagen earned MHA’s highest honor, the Platinum Bell Seal for Workplace Mental Health, for its supportive workplace culture, mental health care benefits, emphasis on inclusion, and employee wellness programs. “Our mission and dedication to improving global mental health with groundbreaking therapies for anxiety, depression, and other psychiatric disorders starts with a collective team effort within our own organization and by prioritizing our employees’ mental health and well-being at work and beyond while we continue to make remarkable progress in our late clinical-stage neuropsychiatry programs. An essential element of our strategy is normalizing conversations about mental health and encouraging individuals to access our extensive support resources. This is an important time to highlight mental health. We are honored to have received Mental Health America’s 2024 Platinum Bell Seal for Workplace Mental Health. We thank MHA for once again recognizing our ongoing commitment to our team’s mental health,” said Shawn Singh, CEO of Vistagen.

To view the full press release, visit https://ibn.fm/FoEU0

About Vistagen Therapeutics Inc.

Vistagen is a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders. Five of Vistagen’s clinical-stage neuroscience pipeline candidates belong to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms of action that activate chemosensory neurons in the nasal passages to impact fundamental neural circuitry in the brain without the need for systemic absorption or binding to receptors in the brain. Vistagen’s sixth investigational candidate is an oral prodrug with potential to inhibit, but not block, NMDA receptor activity. Vistagen is passionate about delivering differentiated treatments that set new standards of care for people living with anxiety, depression and other neurological disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Announces Q3 Player Activity Milestones

June 27, 2024 10:38:56

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company delivering innovative mobile live dealer technology to online gaming operators globally, today announced key milestones for Q3 2023 ending in September. Among the highlights, the company announced that its player activity continues to scale at its live dealer tables since last quarter. Playgon’s quarterly wagering turnover increased to $449,000,000, a 10% increase from $409,000,000 in Q2 2023. “Our sales and integration pipeline continues to be strong, and our business continues to scale,” said Darcy Krogh, CEO of Playgon Games Inc. “The industry remains strong and Playgon is well positioned to participate in the ongoing growth. We look forward to announcing new games, new markets and new partnerships soon.”

To view the full press release, visit https://ibn.fm/6YUbj

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, the company’s products are ideal turnkey solutions for online casinos, sportsbook and land-based operators, media groups, and big database companies. For further information, please visit the company’s website at www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

3rd Transparency & Aggregate Spend Summit: Key Takeaways

June 27, 2024 08:50:00

The 3rd Transparency & Aggregate Spend Summit, held on June 3-4, 2024, in Philadelphia, focused on the latest challenges and solutions in HCP spend reporting compliance for the life sciences industry. Attendees delved into new state requirements, global transparency, and data analytics, with special attention to CMS audits. The speaking faculty included colleagues from Johnson & Johnson, Roche Diagnostics, and Takeda.

The event featured interactive breakout groups and expert-led sessions, fostering deep discussions on improving data capture and compliance processes. Key topics included strategies for managing state reporting requirements and leveraging data analytics for compliance efficiency. The summit provided a…

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – GRN Holding Corp. (GRNF) Rebranding with Marijuana Icon Leading at Helm

June 26, 2024 12:55:08

GRN Holding (OTC: GRNF), a publicly quoted company focused on the global distribution and sale of marijuana in jurisdictions where it is legal, is in the process of a strategic rebranding initiative; the company is rebranding to Marijuana Inc. According to the announcement, the rebranding strategy represents “a new era of growth and innovation in the global cannabis industry.” This transformation is being led by Donald Steinberg, who has been involved in the marijuana space for more than 50 years and has been called the “Henry Ford of the marijuana industry.” Steinberg’s contributions to the world of marijuana have been well documented. Highlights of his career include being recognized by Centac, a U.S. government agency, as the largest importer of marijuana into the United States in the 1970s and the largest U.S. distributor; being interviewed by American journalist and talk show host Charlie Rose; cofounding One World Communications, one of the world’s largest affiliate marketing companies in the international telecom industry, with more than 200,000 members in 30-plus countries; and cofounding Medical Marijuana Inc., the first company on a U.S. stock exchange dedicated to the marijuana industry. With Steinberg at the helm, Marijuana Inc. is focused on revolutionizing the marijuana industry by leveraging his extensive experience, innovative vision and strategic global partnerships. “As many countries relax their laws on marijuana, I see an opportunity to be involved at the beginning of a new chapter in the marijuana industry,” said Marijuana Inc. founder Donald Steinberg in the press release. “Moving ahead with this idea, I formed Marijuana Inc., took control of an existing public company and merged the two entities to pursue growth opportunities. The name change has been filed, and we are awaiting final approval from OTC now.”

To view the full press release, visit https://ibn.fm/Hg3Cw

About GRN Holding Corporation

GRN Holding Corporation is a publicly quoted company focused on the global distribution and sale of marijuana in jurisdictions where it is legal. The company collaborates with marijuana farmers to distribute high-grade, affordable marijuana to legal consumers, wholesalers and retailers. With a team of seasoned professionals experienced in the publicly traded marijuana space, GRN Holding Corporation is committed to driving industry innovation and growth. Marijuana Inc. was founded by Donald Steinberg and is dedicated to providing high-quality cannabis products at competitive prices. The company focuses on controlling the quality of seeds, growing practices, distribution and delivery to consumers. Through its branded and curated heirloom collections, Marijuana Inc. aims to offer unique strains that stand out in the market, ensuring quality, variety and fair pricing. For more information about the company, please visit www.MarijuanaInc.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Adds New Client as Two K5 ASRs Are Deployed to Self-Storage Locations

June 26, 2024 12:16:42

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, is continuing to make notable inroads in providing safety and security for a growing number of clients; the company just announced two new K5 Autonomous Security Robot (“ASR”) deployments for a self-storage company.

According to the announcement, the self-storage company is one of the fastest-growing self-storage platforms in the United States with assets located primarily in high-density, urban markets. By patrolling two of the client’s California storage locations, the proprietary K5 ASRs mitigate risk and elevate protection for tenants and their belongings.

“In addition to their security duties, the robots will broadcast helpful messages to passersby and act as brand ambassadors,” stated the company in the press release. “The client is eagerly waiting to gauge the success of these initial deployments as they consider deployments at many other store locations.”

To view the full press release, visit https://ibn.fm/oOjIh

About Knightscope, Inc.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Continues Expansion Efforts in Northeast with Announcement of New Partnership

June 26, 2024 10:55:36

Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, has entered a key partnership with Atlantic Beverage Distributors, a leading distributor of craft beer, wines, spirits and nonalcoholic beverages and snacks. According to the announcement, the partnership marks the next step in the company’s expansion plan in strategic markets in the northeast. A significant player in the distribution industry since its founding in 1995, Atlantic Beverage Distributors began by distributing specialty beer and wine not represented by volume wholesalers and has since evolved to feature the most sought-after brands. This new partnership follows Safety Shot’s announcement of another partnership focused on the northeast region: Prime CSB. Prime CSB will provide distribution in New York and New Jersey while Atlantic Beverage Distributors will be providing Safety Shot products to consumers in Massachusetts and Rhode Island. “Partnering with Atlantic Beverage Distributors is a significant milestone for the company,” said Safety Shot chief revenue officer Josh Wager in the press release. “Their expertise in the beverage and spirits industry and dedication to working with specialty products align perfectly with where we want to take Safety Shot as we continue to grow and expand. We are confident that this partnership will enhance our distribution capabilities and help us connect with more consumers in the Northeast.”

To view the full press release, visit https://ibn.fm/TAMFh

About Safety Shot Inc.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases FY Financial Report, Business Update

June 26, 2024 10:42:09

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options for mental-health disorders, is reporting its audited financial results for the fiscal year ended March 31, 2024; the report also included a business overview. Highlights of the report include the company receiving U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation (“BTD”) for CYB003, Cybin’s proprietary deuterated psilocybin analog in development for the adjunctive treatment of major depressive disorder (“MDD”); the competition of clinical site selection for a phase 3 multinational study of CYB003, which is expected to begin in summer 2024; the initiation of a phase 2 study of CYB004, Cybin’s proprietary deuterated dimethyltryptamine (“DMT”) program in development for the treatment of generalized anxiety disorder (“GAD”); and the strengthening of the company’s intellectual property portfolio with more than 60 granted patents and 200 pending applications. In addition, the company reported a cash total of C$209 million as of March 31, 2024, with a closed oversubscribed private placement of $150 million involving a syndicate of leading biopharmaceutical institutional investors. “I am proud of the swift and meaningful progress we have made advancing our two lead programs – CYB003 for the adjunctive treatment of MDD and CYB004 for the treatment of GAD – this past year,” said Cybin CEO Doug Drysdale in the press release. “As we stand poised to commence our phase 3 study of CYB003, Cybin has evolved into a mature, late-stage company with critical milestones on the near-term horizon. Supported by the BTD from the FDA and positive four-month durability data for our CYB003 program, and the initiation of our phase 2 study of CYB004, we are progressing quickly to potentially change the treatment paradigm for MDD and GAD and bring to market innovative treatment options for patients in need. The path towards approval and commercialization for such novel therapeutics is gaining clarity. We believe our rigorous research and novel clinical approach can lead to a wholesale transformation in how mental health disorders are treated and ultimately, to improved outcomes for patients and their families.”

To view the full press release, visit https://ibn.fm/adVcN

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental-health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the adjunctive treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD

June 26, 2024 10:27:18

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced that it has awarded a contract to its contract research organization (“CRO”) partner AmplifyBio for an investigational new drug (“IND”)-enabling large animal GLP (Good Laboratory Practice) study of its lead asset, SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (“PTSD”). According to the announcement, the GLP study will evaluate a 28-day repeat intranasal dosing with a 14-day recovery. “Silo has partnered with AmplifyBio since 2022. Our longstanding collaboration has played a key role in advancing SPC-15 through multiple successful pre-clinical studies,” said Silo CEO Eric Weisblum. “A successful IND large animal GLP study is the final study that should facilitate seeking U.S. Food and Drug Administration (‘FDA’) permission for first-in-human clinical studies in PTSD patients and would constitute a significant milestone achievement for the company.”

To view the full press release, visit https://ibn.fm/SijoX

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with universities and independent laboratories. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – OneMedNet Corporation (NASDAQ: ONMD) Announces $1.5M Private Placement

June 26, 2024 09:16:51

OneMedNet (NASDAQ: ONMD, ONMDW), the leading curator of regulatory-grade Imaging Real World Data (“iRWD”) through its proven OneMedNet iRWD(TM) solution, has entered into a standby equity purchase agreement (“SEPA”) with YA II PN, Ltd, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP. According to the forms filed with the U.S. Security and Exchange Commission, OneMedNet the option to sell to Yorkville up to $25 million of the company’s shares of common stock, par value $0.0001 per share “at the company’s request from time to time following both the repayment of the promissory note. . . and the effectiveness of a resale registration statement covering the shares of issued under the SEPA. The SEPA terminates on its 24-month anniversary.” The company also paid a $25,000 structuring fee to Yorkville and agreed to pay a commitment fee of $500,000 to Yorkville; that payment will be paid in shares in two tranches. EF Hutton served as exclusive placement agent on the transaction. EF Hutton served as exclusive placement agent on the $1.5 million private placement.

For more information, visit https://ibn.fm/z5LrQ

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of more than 1,400 healthcare system and provider sites that currently comprise its iRWD(TM) network. OneMedNet’s proprietary iRWD platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results and uniquely medical imaging. Employing its robust OneMedNet iRWD solution, OneMedNet securely deidentifies, searches and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic artificial intelligence (“AI”) development customers. OneMedNet’s platform is designed to meet the clinical requirement necessary across various domains, including but not limited to rare diseases, oncology and cardiology. The company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information about the company, please visit www.OneMedNet.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Has 550,000 Common Shares Acquired by Investor

June 26, 2024 09:05:20

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a publicly traded energy company based in western Canada specializing in the exploration, development and production of crude oil and natural gas, has had 550,000 common shares acquired by Vittorio Valsecchi. The shares were acquired for approximately C$0.065 per common share, for a total cost of C$35,750. Prior to the transaction, Valsecchi beneficially owned 42,450,000 common shares of the company, which represented an estimated 9.94% of the issued and outstanding common shares on a nondiluted basis. “As a result of the acquisition, Mr. Valsecchi now beneficially owns 43,000,000 common shares, representing approximately 10.07% of the issued and outstanding common shares of the company on a nondiluted basis,” stated the press release. “Mr. Valsecchi acquired the common shares for investment purposes. Mr. Valsecchi may acquire additional securities of the company in the future, may dispose of some or all of the securities or may continue to hold his current position.”

To view the full press release, visit https://ibn.fm/9Ty1P

About Prospera Energy Inc.

Prospera Energy is a publicly traded energy company based in western Canada, specializing in the exploration, development and production of crude oil and natural gas. Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir-development methods and production practices. Prospera was restructured in the first quarter of 2021 to become profitable and in compliance with regulatory, environmental, municipal, landowner and service stakeholders. The company is in the midst of a three-stage restructuring process aimed at prioritizing cost-effective operations while appreciating production capacity and reducing liabilities. Prospera has completed the first phase by optimizing low-hanging opportunities and attaining free cash flow while also bringing operations to safe operating condition, all while remaining compliant. Currently, Prospera is executing phase 2 of the restructuring process, the horizontal transformation intended to accelerate growth and capture the significant remaining reserves (400 million bbls). These horizontal wells allow PEI to reduce its environmental and surface footprint by eliminating the numerous vertical well leases along the lateral path. Phase 3 of Prospera’s corporate redevelopment strategy is to optimize recovery through EOR applications. Further, Prospera will pursue its acquisition strategy to diversify its product mix and expand its core area. Its goal is to attain 50% light oil, 40% heavy oil and 10% gas. PEI continues to apply efforts to minimize its environmental footprint as well as efforts to reduce and eventually eliminate emissions while also pursuing innovative ESG methods to enhance API quality, thereby achieving higher margins and eliminating the need for diluents. For more information, visit the company’s website at www.ProsperaEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to GXRFF are available in the company’s newsroom at https://ibn.fm/GXRFF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – RJD Green Inc. (RJDG) Eyes Additional Revenue, Profit Opportunities Through Silex Holdings Division

June 25, 2024 14:28:49

RJD Green (OTC: RJDG) today announced that its Silex Holdings division has procured the rights for sales, distribution and installation of several products scheduled for launch in August of this year. Through procurement efforts of the newly formed dba Silex Holdings Sales and Services, the company has secured sales and installation rights for various new products that are all synergistic to Silex’s core focus of the manufacturing of multiple products from countertops to walls from granite, quartz, marble, quartzite, and other stone materials. “Our Silex Holdings team has enhanced their opportunities through multiple sales and installation rights for four new cabinetry products, flooring, tile, commercial and residential doors, facets, and hardware. These products offer our customers the opportunity to purchase many of their needs in a ‘one-stop’ process for their projects whether homebuilders, commercial contractors, remodelers or retail DIY,” said RJDG CEO Ron Brewer. “We are excited about the additional revenue and profit opportunities Silex is creating in our four-state focus that also enhance the Silex brand and capabilities.”

To view the full press release, visit https://ibn.fm/exp0t

About RJD Green Inc.

RJD Green operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSoft Systems, which provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies; and Silex Holdings Division, which is focused in specialty construction and industrial services. The initial operations, Silex Interiors, fills a market niche between the Home Depots and local contractors. Silex manufactures and installs granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and DIY customer.

NOTE TO INVESTORS: The latest news and updates relating to RJDG are available in the company’s newsroom at https://ibn.fm/RJDG

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – InveniAI LLC Closes on $3.1M Debt Financing

June 25, 2024 13:12:25

InveniAI, a global leader in the application of artificial intelligence (“AI”) and machine learning (“ML”) tools to revolutionize drug discovery and development, has closed on its recent debt financing. According to the announcement, the financing was for an estimated $3.1 million. InveniAI is focused on transforming the discovery and development of life-changing therapies and products with AI-powered technology; the company’s objective is to improve human health and the quality of life. InveniAI has been working for more than a decade to solve real-world problems for the pharmaceutical industry. The company’s efforts led to the creation of an industry-leading technology platform: AlphaMeld(R), which has been crucial in delivering significant clinical, transactional and strategic impact for more than 150 biopharma industry collaborations. ThinkEquity served as an advisor to the InveniAI on the debt financing transaction.

About InveniAI LLC

InveniAI LLC stands as a global frontrunner in the application of artificial intelligence (“AI”) and machine-learning (“ML”) tools, catalyzing innovation throughout drug discovery and development. With a mission to identify and expedite transformative therapies for diseases with unmet medical needs, InveniAI utilizes its cutting-edge AlphaMeld platform to extract valuable insights from petabytes of diverse data sets, propelling the creation of groundbreaking drug programs. The company’s pioneering approach is underscored by successful collaborations with industry leaders and drug spinouts, solidifying its position as a trailblazer in the realm of AI-driven drug discovery. For additional information about the company, please visit www.InveniAI.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray

June 25, 2024 11:34:43

Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the largest distributor in the world of freeze-dried Acai (a potent antioxidant) to develop a highly bioavailable, multi-antioxidant oral spray. This breakthrough product is expected to be commercially available by fall 2024. “This partnership combines the strong synergistic capabilities of two companies: Vita-Forte with direct access to the highest quality oil-based antioxidant ingredients, and PBIO with the best-in-class science-based nanoemulsion processing platform,” said Richard T. Schumacher, president and CEO of PBIO. “The result of this union is expected to help establish the most effective source for both DTC and B2B customers of oil-based nutraceutical products available in the world today, starting with the release this fall of the multi-ingredient, highly bioavailable, ultrapotent antioxidant oral spray.”

To view the full press release, visit https://ibn.fm/sSCp9

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its patented, scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM)) platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PBIO’s patented original enabling platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. Its patented BaroFold(TM) technology platform positions the company to provide valuable contract services and GMP manufacturing equipment to the bio-pharmaceuticals industry. Its commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Partners with Experts in Entertainment, Development and Distribution

June 25, 2024 11:06:57

Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, has entered key partnerships with seasoned veterans who will provide invaluable expertise and support for the company in its entertainment, development and distribution efforts. The partnerships are with Chip Quigley, founder and CEO of Kingdom Entertainment Group, and Ari Freedman, an experienced executive from Surge Brands. According to the announcement, Quigley has more than 20 years of experience in the New York concert business and artist-management space. Freedman has facilitated significant growth and market penetration through development and distribution for several brands. “We are thrilled to partner with Chip and Ari to tap their expertise to further elevate Safety Shot’s market presence through high-profile events and marketing campaigns as well as a strategic oversight on distribution,” said Safety Shot chief revenue officer Josh Wagner in the press release. “Their years of combined experience offer a fresh lens on the brand and bring new perspectives and growth opportunities, ultimately fast-tracking our goal to disrupt the industry with our first-of-its-kind beverage.”

To view the full press release, visit https://ibn.fm/P2934

About Safety Shot Inc.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Unveil New Note-Taking Feature on Proprietary NurseMagic(TM) App

June 25, 2024 09:07:20

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets, has added a notes feature to its NurseMagic(TM) app. According to the announcement, the company’s proprietary app now enables users, including certified nursing assistants (“CNAs”), licensed practical nurses (“LPNs”), Advanced Practice Registered Nurses-Certified Nurse Practitioners (“APRN-CNPs”) and nursing practioners (“NPs”), to create notes in various formats including subjective, objective, assessment and plan (“SOAP”); problem, intervention, and evaluation (“PIE”); and data, action and response (“DAR”). The new feature speeds up the creation of required patient record documentation. Nursing notes are detailed records of a patient’s condition, treatment and prognosis, which are created by nurses during patient care. According to the announcement, a study showed that nurses spend an estimated 40% of their shifts on documentation, so reducing documentation burden is a high priority for the nursing profession. “We have been encouraged and inspired by nurse influencers like Cynesse and Nurse Tara, who are rapidly bringing awareness of the power of NurseMagic to their communities,” said Amesite CEO Dr. Ann Marie Sastry in the press release. “We are learning at an incredibly fast rate from our users and are seeing nurses use NurseMagic to write nursing notes. Our aim is to have our app available to every nurse, as quickly as possible — to help them advance, reduce their stress and improve their professional performance.”

To view the full press release, visit https://ibn.fm/pNXaO

About Amesite Inc.

Amesite, an education-tech SaaS company, offers its proprietary learning platform and content services to deploy affordable and effective artificial intelligence (“AI”) for white-labeled online learning programs for colleges and universities. The company’s technology platform leverages cutting-edge AI to offer an innovative out-of-the box, AI-powered learning ecosystem, complete with 24/7 learner support, up-to-date content and ready-to-go programs to quickly deploy and generate revenue. With the announcement of NurseMagic(TM), Amesite has entered the business-to-consumer (“B2C”) AI app market. Amesite has also announced its intention to deliver other apps on its infrastructure including a public safety app that offers training and preparedness for active-shooter response. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Financial Report for Fiscal Year

June 25, 2024 08:59:51

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is reporting on its financial results for the fiscal year ended March 31, 2024. Highlights of the report show the company gathered positive interim results from its ongoing phase 2 trial for IGC-AD1; updated information TGR-63, IGC’s drug candidate, which targets amyloid-beta plaque; received three patents; signed a master cooperation agreement with the University of Los Andes (faculty of engineering) to conduct research in artificial intelligence (“AI”) applied to the pharmaceutical industry; signed several share purchase agreements with multiple investors, resulting in approximately $6 million in gross proceeds; and began patient enrollment for its phase 2 trial investigating IGC-AD1 to treat agitation in dementia due to Alzheimer’s disease. Financial highlights from the report indicate approximately $1.3 million in revenue, an increase from the $911,000 reported in fiscal 2023; selling, general and administrative (“SG&A”) expenses for fiscal 2024 reaching approximately $6.7 million; and research and development expenses of approximately $3.8 million. “During the fiscal year we accomplished multiple key milestones and significantly advanced our strategy to bring to market treatments to fight Alzheimer’s, a devastating disease affecting a growing patient population around the globe,” said IGC Pharma CEO Ram Mukunda in the press release. “The most important achievement in our development pipeline was the positive interim results on IGC-AD1, a significant development in the fight against Alzheimer’s and a reflection of our commitment to advancing our product portfolio and delivering value to all stakeholders. . . . We appreciate the dedication and hard work of our team, whose efforts have been instrumental in achieving these results. We remain focused on executing our strategic initiatives and are excited about the opportunities that lie ahead.”

To view the full press release, visit https://ibn.fm/7sGuB

About IGC Pharma

IGC Pharma is focused on Alzheimer’s disease, developing innovative solutions to address this devastating illness. The company’s mission is to transform the landscape of Alzheimer’s treatment with a robust pipeline of five promising drug candidates. IGC-AD1 and LMP target the hallmarks of Alzheimer’s disease, including neuroinflammation, Aβ plaques and neurofibrillary tangles. IGC-AD1 is currently undergoing a phase 2 clinical trial for agitation in dementia associated with Alzheimer’s. TGR-63 disrupts the progression of Alzheimer’s by targeting Aβ plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of Aβ plaques, potentially impacting early-stage Alzheimer’s. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer’s therapy. In addition to its drug-development pipeline, IGC Pharma seeks to leverage artificial intelligence (“AI”) for Alzheimer’s research. The company’s AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer’s. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ROTH to Host 10th Annual London Conference with a Focus on Sustainability and Technology

June 24, 2024

June 24, 2024 12:35:00

ROTH is excited to invite companies, entrepreneurs, industries, and businesses to attend the 10th Annual ROTH London Conference, taking place from June 25-27, 2024, at the Four Seasons Hotel London at Park Lane. This event is a premier gathering for small-cap companies, providing significant growth and networking opportunities.

The conference will feature 1-to-1 meetings lasting 40 minutes each, allowing investors and companies to engage in-depth on various sectors, including sustainability, agtech, E&P, metals and mining, and technology. These intimate group meetings are designed to facilitate detailed discussions and…

For more information and to register for the conference, visit the ROTH website.

Companies interested in scheduling one-on-one meetings can contact their ROTH representative directly.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Issues Update on Financial Reports, Recent Business Developments

June 24, 2024

June 24, 2024 10:55:55

HUB Cyber Security (NASDAQ: HUBC) (“HUB”), a developer of confidential computing cybersecurity solutions and advanced data services, today released a statement regarding the recent announcement published on May 23, 2024. The company clarified that it is on track to release its annual financial reports within the next few weeks. In addition, HUB has secured two deals with governmental entities, highlighting its commitment to strategic expansion and enhancing its offerings. The company expects significant progress in its secure data fabric vertical by the end of the next quarter.

To view the full press release, visit https://ibn.fm/A0aL6

About HUB Security Ltd.

HUB Cyber Security (“HUB”) was established in 2017 by veterans of the elite intelligence units of the Israeli Defense Forces. The company specializes in unique cybersecurity solutions protecting sensitive commercial and government information. The company debuted an advanced encrypted computing solution to prevent hostile intrusions at the hardware level while introducing a novel set of data theft prevention solutions. HUB Security operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Reports Growing Demand for ZVS Inverter

June 24, 2024

June 24, 2024 10:22:13

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative clean-technology company specializing in power-conversion technologies, is seeing increased interest in its ZVS inverter and has announced that demonstration slots for new customers are being scheduled into next year. Hillcrest inverters, which feature the company’s proprietary Zero Voltage Technology (“ZVS”) platform, provide superior electromagnetic compatibility and deliver an industry-leading efficiency of up to 99.7%, which translates into a cost savings of up to $2,200 per vehicle in electric-vehicle (“EV”) traction applications. In addition, the ZVS inverter provides exceptional efficiency and enhances power quality in stationary, grid-connected applications. “The demand from potential customers in both electric vehicle (‘EV’) and stationary applications is accelerating as we continue to adapt to customer feedback, improve our technology and generate even more impressive test results,” said Hillcrest Energy Technologies CEO Don Currie in the press release. “Between the burgeoning pipeline of demonstration requests and our product-development efforts with partners like Ocean Batteries AS and several European automotive manufacturers, we are approaching full capacity this year. New customer demonstrations not already in our pipeline are being scheduled into early 2025, a very positive indicator of the expanding interest in our technology.”

To view the full press release, visit https://ibn.fm/6DNeY

About Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies is a clean-technology company focused on providing advanced power-conversion technologies and digital-control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. For more information about the company, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Zoomcar Holdings Inc. Closes $3.6M Private Placement of Non-Convertible Promissory Notes and Warrants

June 21, 2024 12:39:35

Zoomcar Holdings (NASDAQ: ZCAR), a marketplace for car sharing in emerging markets, recently announced the closing of a private placement. According to the announcement, the company closed the purchase and sale of approximately $3.6 million of promissory notes and investor warrants for expected aggregate gross proceeds of $3 million with institutional investors. The private placement consisted of the sale of senior non-convertible notes in an aggregate principal amount of $3,600,000 and warrants to purchase approximately 53 million shares of company common stock with an exercise price of $0.1416 per unit. The notes, issued at an original issue discount of approximately 16.67%, will bear interest at 15% per year unless an event of default has occurred, upon which interest accrues at 20% per year. The warrants are exercisable beginning on the later of (a) the six-month anniversary of issuance and (b) the date the company’s stockholders provide approval. Zoomcar intends to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as the exclusive placement agent for the private placement.

To view the full press release, visit https://ibn.fm/IuHsI

About Zoomcar Holdings Inc.

Founded in 2013 and headquartered in Bengaluru, India, Zoomcar is a marketplace for car sharing focused on emerging markets. The Zoomcar community connects Hosts with guests, who choose from a selection of cars for use at affordable prices, promoting sustainable, smart transportation solutions in growing markets. For more information, please visit www.zoomcar.com

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Satoshi Island Appoints Brian J. Esposito as New Head of Global Strategy

June 21, 2024 11:45:22

Satoshi Island, the pioneering regenerative high-tech community development in Vanuatu, has appointed Brian J. Esposito, a visionary leader with extensive experience in strategy and innovation, as the new Head of Global Strategy. According to the announcement, Esposito, who brings a wealth of knowledge and a proven track record of success in strategic roles across various industries, will be instrumental in driving Satoshi Island’s strategic direction and growth. His expertise is expected to be pivotal in realizing Satoshi Island’s vision of creating a sustainable, autonomous and technologically advanced community. “Having Brian on board is a significant milestone for Satoshi Island. His strategic insights and innovative approach will undoubtedly elevate our project to new heights. We are confident that his leadership will be instrumental in achieving our ambitious goals,” said Denys Troyak, Head of Hospitality at Satoshi Island.

To view the full press release, visit https://ibn.fm/sd2xs

About Satoshi Island

Satoshi Island is a regenerative, high-tech community development in Vanuatu, combining the principles of sustainability, innovation, and cultural preservation. The project includes modular construction, renewable energy and a decentralized governance model, aiming to create a self-sustaining and eco-friendly community. For more information, visit www.satoshi-island.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI Holdings Inc. (ECGI) Extends Commitment to Building High-Quality, Luxury Brands with LOI to Acquire Pacific Saddlery, Opening Door to Greater Equestrian Equipment Market

June 21, 2024 10:20:00

ECGI Holdings recently signed a LOI to acquire Pacific Saddlery, a renowned manufacturer and retailer of luxury equestrian tack, apparel, and accessories
According to the company, the acquisition strategically aligns with its objectives of expanding its presence in the luxury brands sector
The acquisition is expected to generate new recurring revenue streams and enable ECGI to capture a share of the luxury equestrian market as well as the broader global equestrian market
The larger global equestrian market, which is segmented into equestrian apparel and equestrian equipment, is expected to grow to $26.7 billion by 2032 from $17.5 billion in 2023

ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture and luxury fashion, has been strategically shifting its focus as it ventures into a future defined by innovation, luxury, and a commitment to building high-ROI brands that will stand the test of time. This follows the December 2023 signing of a joint venture share purchase agreement with Nick Collins, a well-known professional in the equestrian luxury market, creating Pacific Saddlery Inc. (https://ibn.fm/h0W0t).

“In line with our ongoing evolution, this joint venture with Nick aligns with ECGI’s new direction, emphasizing a commitment to building luxury brands,” said Jamie Steigerwald, CEO of ECGI, in a…

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Presentation at Virtual Life Sciences Investor Forum Made Available for Online Viewing

June 21, 2024 09:32:35

Longeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions. Longeveron presented at the Virtual Life Sciences Investor Forum on June 20. The company’s presentation is now available for online viewing 24/7 for 90 days.

To view the presentation, visit https://ibn.fm/RYzP8

To view the full press release, visit https://ibn.fm/VntPI

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease, and Aging-related Frailty. The Lomecel-B HLHS program has received three distinct and important U.S. FDA designations: Orphan Drug, Fast Track and Rare Pediatric Disease designations. For more information about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Filing of 2023 Annual Report with SEC

June 21, 2024 08:22:58

iClick (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, announced that it filed its 2023 annual report on Form 20-F. Filed with the U.S. Securities and Exchange Commission (“SEC”) on June 20, 2024, the annual report on Form 20-F contains the company’s audited consolidated financial statements for the fiscal year ended December 31, 2023. It can be accessed on the SEC’s website as well as iClick’s investor relations website.

To view the full press release, visit https://ibn.fm/cwquO

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) Meridianbet Granted License to Enter South African Market

June 21, 2024 07:35:00

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, is announcing that its subsidiary Meridianbet, a B2B and B2C sports betting and gaming platform, has received a sports-betting license in South Africa. The license, granted by the Western Cape Gambling and Racing Board, confirms Meridianbet’s expansion into the South African market. According to the announcement, the Western Cape Gambling and Racing Board granted Meridianbet a Bookmaker License, a Bookmaker Premises License, and a Manufacturer License. “We are thrilled to enter the South African market, and this new license presents a significant opportunity for us to continue to scale our operations,” said Zoran Milosevic, CEO of Meridianbet. “Expanding our reach into South Africa will provide new opportunities to grow our user base in an entirely new jurisdiction, underscoring our ongoing commitment to growing our industry-leading brands around the world.”

To view the full press release, visit https://ibn.fm/QFtQD

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients and RKings, its B2C division, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. Besides Meridianbet and Expanse Studios, the company also owns and operates MEXPLAY, a regulated online casino in Mexico. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New Contract with the New York City Fire Department

June 20, 2024 12:48:59

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has signed a new contract with the New York City Fire Department (“FDNY”). According to the announcement, the FDNY has subscribed to the Knightscope Emergency Management System (“KEMS”) software that will monitor their 518 Call Boxes across Queens, Manhattan, the Bronx, and Brooklyn.

“Keeping the city safe is a key to community wellness. Knightscope helps establish that feeling of comfort and safety in communities with its familiar K1 emergency call boxes that provide highly recognizable points to establish reliable, one-touch communication with FDNY,” the announcement reads. “The KEMS platform allows clients and technicians to better understand the real-time health and status of deployed emergency communication devices and receive immediate text/email notification whenever a help button is pressed.”

To view the full press release, visit https://ibn.fm/yFSpq

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety, and its long-term ambition is to make the United States of America the safest country in the world. For more information or to book a discovery call or demonstration, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

GSMI Talent Acquisition Week Brings In Three Conferences For A Comprehensive Learning Experience

June 20, 2024 12:35:00

TA pros, HR leaders, managers, and executives, gather together to share and learn time-tested strategies for social recruiting, talent sourcing & recruiting, DEI, talent data analytics, and employer branding, at the GSMI Talent Acquisition Week being held from July 22-26, 2024, as a virtual event.

The #TA_Week offers a full week of learning, exploration, discussions, and networking through the Social Recruiting Strategies Conference (#SRSC), Employer Branding Strategies Conference (#EBrandCon), and Talent Sourcing Strategies Summit. The event will witness…

To learn more, please visit https://ibn.fm/vABds

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Sustainable Green Team Ltd. (SGTM) Enters Definitive Agreement to Acquire Regen Hubs, HumiRock

June 20, 2024 12:25:00

Sustainable Green Team (OTC: SGTM), a leading provider of sustainable agricultural solutions, has entered into a binding Letter of Intent (“LOI”) to acquire Regen Hubs North America, Inc., Regen Hubs International, Inc., and HumiRock, LLC, along with their affiliates. SGTM noted the strategic acquisition, upon completion, represents a significant milestone in its mission to revolutionize sustainable agricultural practices worldwide and position it at the forefront of sustainable agriculture. The company expects to leverage the extensive professional and geographical networks that Regen Hubs developed to expand its reach and drive positive change in the industry. According to the announcement, SGTM and Regen Hubs have collaborated with Worldwide TV Products to develop a comprehensive plan for selling, packaging, and distributing SGTM’s full range of products to retailers in North America. In addition, SGTM and Regen Hubs will collaborate to develop a comprehensive plan for the sale, packaging, and distribution of SGTM’s complete suite of products across various market sectors. Regen Hubs is a leading organization focused on improving soil health, reducing chemical usage, and enhancing farmers’ profitability through cutting-edge technology and strong partnerships. “We are thrilled about this incredible opportunity to join forces with Regen Hubs and HumiRock. Together, we expect to revolutionize sustainable agricultural practices and contribute to a greener future,” said Tony Raynor, CEO of SGTM.”

To view the full press release, visit https://ibn.fm/ChbVm

About Sustainable Green Team Ltd.

Sustainable Green Team is a leading company in climate-reversing technologies, a provider of sustainable solutions to improve environmental health and promote sustainable practices, delivering ecofriendly products and services. SGTM aims to make significant contributions to global sustainability. For more information about the company, please visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Nightfood Holdings Inc. (NGTF) Solves America’s Nighttime Snacking Problem with Science-Backed Sleep-Friendly Snacks

June 20, 2024 11:50:00

Humans are biologically hardwired to crave high-calorie foods at night. Those high-sugar, high-fat options are understood to be unhealthy, and they can also directly impair sleep quality
NGTF provides sleep-friendly options for nighttime snacking, with snacks formulated by sleep and nutrition experts specifically for snacking in the hours before bed
Nightfood cookies contain prebiotic fiber for gut health, inositol for anxiety reduction and improved sleep, gluten-free oat flour for easy digestion, and vitamin B6 for melatonin synthesis, mood and sleep regulation
Other key ingredients include allulose and monk fruit for great taste without blood sugar spikes plus slow-digesting micellar casein protein for satiety and blood sugar support

Humans are biologically hardwired to crave high-calorie, sweet, and high-fat foods in the evening. At night, appetite peaks, cravings spike, and willpower drops.

This perfect storm results in over 90% of Americans snacking regularly at night, with the average adult snacking before bed 3.9 nights per…

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market

June 20, 2024 11:31:29

Vision Marine Technologies (NASDAQ: VMAR),a pioneer in electric marine propulsion, today announced its partnership with JetRide Holding LLC, a Florida members-only boat club. The strategic alliance marks Vision Marine’s expansion in the burgeoning electric boat rental market, leveraging JetRide’s extensive network of over 17 boat club locations across Florida. The company believes that the electric boat market is experiencing rapid growth, driven by increasing awareness and demand among both seasoned boaters and newcomers. Vision Marine is positioned for opportunity as, similar to the rise of electric cars, electric boats become essential in the boating world. “Rental operations are the perfect platform to promote and showcase our innovative products and serves as the best marketing platform for future boat buyers’ education,” said Alex Mongeon, CEO of Vision Marine. “This partnership is a significant step towards promoting sustainable and thrilling boating experiences.”

To view the full press release, visit https://ibn.fm/bT0rM

About Vision Marine Technologies Inc.

Vision Marine Technologies epitomizes the marine industry’s shift towards electric propulsion, offering the pioneering E-Motion(TM) outboard powertrain system. The company believes this innovative technology represents a significant leap forward in marine propulsion, combining advanced battery packs, inverters and high-efficiency motors with proprietary software and assembly techniques. Vision Marine’s commitment to eco-friendly electric powerboats is designed to reshape the recreational boating experience, offering higher speeds, longer ranges and smoother rides than traditional internal combustion engine boats. With a focus on design, innovation and craftsmanship, Vision Marine aims to redefine recreational boating for a more sustainable future. For more information, visit the company’s website at www.VisionMarineTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to VMAR are available in the company’s newsroom at https://ibn.fm/VMAR

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Provides Statement Regarding Settlement with Oppenheimer & Co.

June 20, 2024 10:06:43

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, has released a statement regarding recent press reports about a settlement with Oppenheimer & Co. The statement reads, “The company confirms that it is making progress towards reaching a settlement regarding a $12 million dispute. The settlement process is moving forward with Oppenheimer & Co. to resolve the claims related to unpaid fees for SPAC merger-related services.”

To view the full press release, visit https://ibn.fm/veQyL

About HUB Security Ltd.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Reports ‘Fastest Growth’ in Usership of Its NurseMagic(TM) App

June 20, 2024 09:18:24

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced user growth on its NurseMagic(TM) app. The company made the app available to the public in April, inviting users to join a gated waitlist of vetted users. On June 5, Amesite fully opened access to the app to the public. The announcement noted that within a week, nearly 1,200 individuals completed an onboarding survey and registered as app users. “This is the fastest growth in usership that we have ever seen with any of our products. We’ve been thrilled with the response from nurses, and fortunate to partner with nurse influencers like Cynesse – who are demonstrating to their communities the power of AI to help with day-to-day tasks. We are excited to be delivering a vital and useful tool to the largest segment of healthcare professionals and believe that NurseMagic(TM) will create a positive impact in healthcare and strong, sustainable revenue growth for Amesite,” said Amesite CEO Dr. Ann Marie Sastry.

To view the full press release, visit https://ibn.fm/i6KaK

About Amesite Inc.

Amesite, an education tech SaaS company, offers its proprietary learning platform and content services to deploy affordable and effective AI for white-labeled online learning programs for colleges and universities. The company’s technology platform leverages cutting-edge AI to offer an innovative out-of-the-box, AI-powered learning ecosystem, complete with 24/7 learner support, up-to-date content and ready-to-go programs to quickly deploy and generate revenue. With the announcement of NurseMagic(TM), Amesite has entered the B2C AI app market. Amesite has also announced its intention to deliver other apps on its infrastructure including a Public Safety app that includes training and preparedness for active shooter response. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Calls Meeting a ‘Milestone’ as FDA Affirms Alignment

June 20, 2024 07:35:00

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, has received formal minutes from its pre-New Drug Application (“NDA”) Type-B Chemistry, Manufacturing, and Controls (“CMC”) meeting with the U.S. Food and Drug Administration (“FDA”). Tonix met with the FDA regarding its product candidate Tonmya(TM), also known as TNX-102 SL, for the management of fibromyalgia. According to the announcement, the meeting was for Tonix Pharmaceuticals officials to identify alignment and agreement with the FDA on key CMC topics as the company prepared to submit an NDA to the FDA.

“We remain encouraged and excited about the prospect of bringing the first new treatment to market for fibromyalgia patients in over a decade, and this encouraging meeting with the FDA is an important milestone as we head into the final stages of completion of the NDA package,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release “During the pre-NDA CMC meeting, the FDA affirmed alignment with Tonix on CMC content and commercial strategy for Tonmya, and we are very appreciative of the FDA’s guidance as we prepare for our NDA submission. We are currently actively preparing a dual manufacturing launch strategy with global contract development and manufacturing organization (CDMO) Almac Pharma Services and another CDMO.”

To view the full press release, visit https://ibn.fm/zuba7

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R)(sumatriptan injection) 3 mg and Tosymra(R)(sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Shares Update on Expected Timing of Next Periodic Report

June 20, 2024 07:35:00

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, has released an update regarding the timing of its next periodic report. The company recently changed its fiscal year from October 31 to December 31 and has recently closed on the acquisition of the MeridianBet Group. According to the announcement, the next periodic report that the combined company is required to file is a quarterly report for the quarter ended June 30, 2024; the company expects to file that report prior to the due date, which is Aug. 14, 2024. “The acquisition is treated as the purchase by the MeridianBet Group of Golden Matrix under accounting principles generally accepted in the United States, or GAAP,” stated the company in the press release. “Under the purchase method of accounting, the assets and liabilities of Golden Matrix will be recorded, as of the completion of the purchase, at their respective fair values, in the financial statements of the MeridianBet Group and the financial statements of the combined company issued after the completion of the acquisition will reflect these values, but will not be restated retroactively to reflect the historical financial position or results of operations of Golden Matrix.”

To view the full press release, visit https://ibn.fm/uul58

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is a leading business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses branded gaming platforms for its extensive list of clients. Its B2C division, RKings, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company also owns and operates MEXPLAY, a regulated online casino in Mexico. Founded in 2001, the MeridianBet Group is a well-established online sports betting and gaming group, licensed and currently operating in 15 jurisdictions across Europe, Africa and South America. The MeridianBet Group’s successful business model utilizes proprietary technology and scalable systems, thus allowing it to operate in multiple countries and currencies and with an omnichannel approach to markets, including retail, desktop online and mobile. Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law. For more information about the company, visit www.GoldenMatrix.com.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Releases Financial Report for Q4, FY 2023

June 20, 2024 07:35:00

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, is reporting its fourth-quarter and full-year 2023 financial numbers, for the period ended Dec. 31, 2023. Notable numbers from the report show revenue for the full year totaling $15.5 million, down an estimated 18.7% from 2022, with gross profit for the full year reported at negative $2.7 million, compared to negative $3.4 million for 2022. Highlights from the report show that Energica Inside, a majority-owned subsidiary of Ideanomics, announced key partnerships to develop all-electric solutions for aviation, marine and off-road uses; Energica electric motorcycles were also selected by police services in France and Barbados for police fleets. In addition, the report showed that Ideanomics charging solutions business, WAVE, has completed an industry-first, OEM-approved installation of wireless charging and is continuing initial projects with several major logistics fleet customers. Members from Ideanomics management team, including CEO Alf Poor and CFO Ryan Jenkins, have recorded an earnings conference call outlining key information from the financial report. “Throughout 2023, Ideanomics continued executing its commitment to shareholders to exit noncore businesses and finalize a reorganization of the business to focus on last-mile and local delivery vehicles and associated charging products,” the company stated in the press release.

To listen to the conference call, visit https://ibn.fm/mHoIf

To view the full press release, visit https://ibn.fm/udW0y

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles and charging technology with design, implementation, and financial services, the company provides the completeness of solutions needed for the commercial world to commit to an EV future. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Featured Presenter at Upcoming H.C. Wainwright Neuro Perspectives Virtual Conference

June 20, 2024 07:35:00

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation, psychedelic-based treatment options, will be spotlighted during an upcoming online fireside chat at the H.C. Wainwright Fifth Annual Neuro Perspectives Virtual Conference. According to the announcement, Cybin CEO Doug Drysdale will present during the virtual event, which is scheduled for June 27, 2024. Drysdale’s presentation will be available beginning at 7 a.m. ET. An archived version of the presentation will be available on the company’s investor relations website.

To view the presentation, visit https://ibn.fm/ZdTxZ

To view the full press release, visit https://ibn.fm/Sm5L7

About Cybin Inc.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Roth Capital Partners Continues Partnership with IBN as Official Marketing Partner for Annual ROTH London Conference

June 18, 2024 13:22:35

Roth Capital Partners (Roth MKM), a relationship-driven investment bank dedicated to serving growth companies and their investors, has once again selected IBN as an official marketing sponsor for this month’s upcoming ROTH London Conference. The event is scheduled for June 25–27, 2024, in London. This year marks the 10th annual gathering of the ROTH London Conference, and the event has become widely recognized for bringing experienced C-suite executives from innovative growth companies together with qualified investors to explore potential collaborations. According to the announcement, as an official marketing sponsor, IBN will leverage its comprehensive corporate communications capabilities to increase awareness and recognition of the conference, particularly among international audiences. Included in IBN’s extensive coverage will be communications regarding the event agenda, speakers, sponsors and other key event elements. This information will be distributed throughout IBN’s syndication network of more than 5,000 partners and portfolio of investor brands, reaching an audience of more than two million followers. “For decades, ROTH has been a leader in transaction management, advisory services and research throughout the small-cap space,” said IBN director of investor communications Jonathan Keim in the press release. “Our team is excited to collaborate with them once again for the upcoming London-based event, and we look forward to leveraging our expansive media networks to strategically target millions of online investors.”

To find out more about the conference, visit https://ibn.fm/3pLR9

To view the full press release, visit https://ibn.fm/CuM1X

About Roth Capital Partners LLC

Roth Capital Partners is a relationship-driven investment bank focused on serving growth companies and their investors. As a full-service investment bank, Roth provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, Roth is a privately held, employee-owned organization that maintains offices throughout the United States. For more information about this company, please visit www.Roth.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Gain Therapeutics Inc. (NASDAQ: GANX) Releases Pricing of Underwritten Public Offering, Projected to Reach $11M

June 18, 2024 13:18:02

Gain Therapeutics (NASDAQ: GANX), a clinical-stage biotechnology company leading the discovery and development of next-generation allosteric therapies, has announced the pricing of an underwritten public offering. The public offering is comprised of 7,116,547 shares of its common stock offered at $1.35 per share and prefunded warrants to purchase 1,031,602 shares of common stock in lieu of shares of common stock to certain investors. According to the announcement, the prefunded warrants will be immediately exercisable. In addition, the company granted the underwriter a 30-day option to purchase up to 1,222,222 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The public offering is projected to total an estimated $11 million in gross proceeds, excluding the exercise of the underwriter’s option and underwriting discounts and commissions and other offering-related expenses. Gain anticipates using the funds from the offering to continue clinical and nonclinical development of its lead product candidate GT-02287, which is designed to treat neurodegenerative diseases including GBA1 Parkinson’s disease, as well as for general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as sole bookrunner for the offering.

To view the full press release, visit https://ibn.fm/Bonxo

About Gain Therapeutics Inc.

Gain Therapeutics is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate GT-02287 for the treatment of GBA1 Parkinson’s disease is currently being evaluated in a phase 1 clinical trial. Leveraging artificial-intelligence (“AI”)-supported structural biology, proprietary algorithms and supercomputer-powered physics-based models, the company’s Magellan(TM) drug-discovery platform can identify novel allosteric binding sites on disease-implicated proteins, pinpointing pockets that cannot be found or drugged with current technologies. Its AI and machine-learning tools and virtual screening capabilities leverage the emerging on-demand compound libraries covering vast chemical spaces of more than five trillion compounds to identify and select suitable small molecule hits for experimental validation. Gain’s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology. For more information, visit the company’s website at www.GainTherapeutics.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Nightfood Holdings Inc. (NGTF) Announces Acquisition of Robotics, Automation Services Provider in Hospitality and Food Services Spaces

June 18, 2024 11:39:55

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, has acquired Future Hospitality Ventures Holdings Inc., a California-based provider of robotics and automation solutions to the hospitality and food service industries designed to deliver improved efficiencies and cost savings. The acquisition is in line with Nightfood’s vision of capitalizing on explosive trends within the hospitality, food service and consumer packaged goods (“CPG”) sectors. According to the announcement, Nightfood is in the process of acquiring additional operating companies in related fields with substantial assets and revenue; the company plans to provide updates regarding these transactions in the coming weeks. “Incorporating Future Hospitality’s advanced AI-enabled robotic solutions positions us at the forefront of innovation in the hospitality sector at this critical point in time,” said Nightfood Holdings CEO Sonny Wang in the press release. “We believe our success in this area can open up new avenues for growth and efficiency across our portfolio. Our customers can benefit from plug-and-play, AI-enabled automation, which integrates easily and seamlessly into traditional restaurants, hotels, health-care facilities, school cafeterias and other food-service operations. There are exponential benefits for customers with a portfolio of locations, which is the market segment we are initially targeting.”

To view the full press release, visit https://ibn.fm/h6iLr

About Nightfood Holdings Inc.

Nightfood is a forward-thinking holding company dedicated to identifying and capitalizing on explosive market trends within the hospitality, food services, consumer packaged goods and commercial real estate sectors. The company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth by leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval. Nightfood is at the forefront of introducing and deploying artificial intelligence-enabled robotics products, revolutionizing operational efficiencies and customer experiences across the company’s focus areas. Additionally, the company is committed to developing and marketing wellness-focused consumer packaged goods, meeting the growing demand for healthier and functional options. Through these strategic initiatives, Nightfood endeavors to drive significant value and growth for its stakeholders. For more information about the company, visit the company’s website at www.NightFood.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at https://ibn.fm/NGTF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ADS-TEC Energy plc (NASDAQ: ADSE) Featured in Coverage of ROTH’s 10th Annual ROTH London Conference

June 18, 2024 08:05:00

ADS-TEC Energy (NASDAQ: ADSE), develops and manufactures battery storage solutions and fast charging systems including their energy management systems. Its battery-based, fast charging technology enables electric vehicles to ultrafast charge even on low powered grids and features a very compact design. With its advanced system platforms, ADS-TEC Energy is a valuable partner for automotive, OEMs, utility companies and charge-operators.

ADS-TEC Energy will be in attendance during the 10th Annual ROTH London Conference. Wolfgang Breme, CFO of ADS-TEC Energy will be available for one-on-one meetings. For more information, visit the company’s website at https://www.ads-tec-energy.com/en.

To schedule a one-on-one meeting, please contact your ROTH representative.

To view IBN’s coverage of the event, visit https://ibn.fm/Roth2024London

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at ROTH’s 10th Annual Roth London Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Share Poster Presentation Featuring Migraine Treatments During AHS Event

June 18, 2024 07:35:00

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, participated in the 66th annual Scientific Meeting of the American Headache Society (“AHS”); the four-day event was held June 13–16, 2024. During the conference, the company presented data in a poster presentation showing that a gap in nonoral prescriptions relative to AHS guidelines represents an opportunity for increased awareness of Tonix’s two FDA-approved, nonoral treatments for acute migraine. According to the company, its Zembrace(R)SymTouch(R)(sumatriptan injection) and Tosymra(R)(sumatriptan nasal spray) are indicated for the treatment of acute migraine in adults.

“We believe personalizing therapy for migraine is the future, and it is hoped that nonoral medicines will address some of the persistent dissatisfaction patients experience with their migraine treatments,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release. “We hope that educating prescribers about the importance of customized treatments will lead to enhanced satisfaction and improve the quality of life of migraine patients. This represents an opportunity for growth in nonoral, first-line therapeutics such Tonix’s Zembrace SymTouch and Tosymra.”

To view the presentation, visit https://ibn.fm/WFXhB

To view the full press release, visit https://ibn.fm/QLBMm

About Tonix Pharmaceuticals Holding Corp.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – N2OFF Inc. (NASDAQ: NITO), Subsidiary Expand Footprint with First-Ever Order from a Peruvian Customer

June 17, 2024 11:33:29

N2OFF (NASDAQ: NITO) (FSE: 80W) (formerly known as Save Foods Inc.), a pioneer agrifood tech company offering sustainable solutions for agriculture and plant-based food, and its subsidiary Save Foods Ltd., have received an initial purchase order from a customer in Peru. Calling this first order “particularly exhilarating, given the remarkable growth of Peruvian agricultural exports on the global stage,” the company noted that the country’s agricultural exports have grown from $645 million in 2000 to approximately $10.5 billion last year. The order came from a leading grower, packer and distributor of avocados. The purchase order was received after the success of Save Food’s first commercial implementation of its solution earlier this year; the company’s proprietary solution is designed to control pathogen contamination and prolong the shelf life of fresh produce while reducing the use of hazardous chemicals. “The Latin American market represents a tremendous opportunity for Save Foods,” said N2OFF CEO David Palach in the press release. “With many countries in the region at the forefront of the global fresh-produce market, we believe our products hold immense potential, whether utilized post- or near harvest.”

To view the full press release, visit https://ibn.fm/Ng125

About N2OFF Inc.

N2OFF (formerly known as Save Foods Inc.) is an innovative agrifood tech company that through its three operational arms delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., N2OFF’s majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. NTWO OFF Ltd., N2OFF’s majority-owned Israeli subsidiary, contributes to tackling greenhouse-gas emissions, offering a pioneering solution to mitigate nitrous oxide (“N2O”) emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. NTWO OFF aims to promote agricultural practices that are both environmentally friendly and economically viable. N2OFF also has a minority ownership in Plantify Foods Inc., a Canadian company listed on the TSX.V that offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic and that use whole natural ingredients and are easy to prepare. For more information about the company, please visit www.N2OFF.com.

NOTE TO INVESTORS: The latest news and updates relating to N2OFF are available in the company’s newsroom at https://ibn.fm/NITO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for $4.4M, Present at Virtual Life Sciences Investor Forum

June 17, 2024 11:18:00

Longeveron (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, today announced its entry into definitive agreements for the exercise of certain existing warrants to purchase an aggregate of 1,697,891 shares of its Class A common stock having an exercise price of $2.35 per share, originally issued in April 2024. The resale of the shares of Class A common stock issuable upon exercise of the existing warrants is registered per an effective registration statement on Form S-1 (File No. 333-278995). The gross proceeds to Longeveron are expected to be approximately $4.4 million, prior to deducting placement agent fees and estimated offering expenses payable by the company. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In addition, the company announced that it will participate in the Virtual Life Sciences Investor Forum taking place on June 20, 2024. Longeveron will participate in a Fireside Chat scheduled to begin at 10:30 a.m. ET on the day of the conference. The webcast may be accessed on the “Events and Presentations” section of the company’s website. A replay will be available on the Longeveron website for 90 days following the conference.

To view the full press releases, visit https://ibn.fm/Dbb86 and https://ibn.fm/cTOLl

About Longeveron Inc.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI Holdings Inc. (ECGI) Secures Financing to Enhance Its Luxury Equestrian Brand Amid Plans to Capture Significant Share of Growing US Market

June 17, 2024 11:05:00

ECGI Holdings signed an agreement in December 2023, creating Pacific Saddlery, Inc., an emerging brand targeting the luxury equestrian apparel, tack, and accessories marketplace, and continues plans to move forward in that market
In support of growth plans, the company recently secured the first of two $125,000 convertible note financings, with the second convertible note expected to close in July
ECGI intends to use the net proceeds from the financings to significantly enhance Pacific Saddlery’s product development, helping the brand expand its offerings and capture a significant share of the U.S. luxury equestrian market
The U.S. luxury equestrian tack and apparel market is valued at $300 million and is expected to grow at an annual rate of 4-6%
Besides tapping into the expected growth, ECGI’s venture into the luxury equestrian market is buoyed by attractive gross and net profit margins

December of 2023 saw ECGI Holdings (OTC: ECGI), a diversified holding company, make a strategic move toward building luxury brands. The company signed a joint venture share purchase agreement, creating Pacific Saddlery, Inc., an emerging brand targeting the luxury equestrian apparel, tack, and accessories marketplace. The agreement aligned with – and continues to align with – ECGI’s ongoing evolution, new strategic direction, and, according to CEO James Steigerwald, “commitment to building luxury brands” (https://ibn.fm/iCPAf).

A widely held belief by ECGI’s management is that the luxury equestrian marketplace is an ideal focus for investment in building a globally respected boutique brand. This belief has seen the company secure financing to facilitate further product development for Pacific Saddlery. The financing follows…

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI) Eyes First Deployment of ZVS Inverter Tech into Stationary, Grid-Connected Applications

June 17, 2024 10:00:28

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative company specializing in power conversion technologies, today announced the completion of a joint development agreement with Ocean Batteries AS for the delivery of 300kVA | 800V Hillcrest ZVS inverter prototypes. Hillcrest will work with Norway-based Ocean Batteries on the design and testing of a ZVS inverter for integration into the company’s onshore energy storage systems and completion of a definitive supply agreement. “Our partnership with Ocean Batteries marks the first deployment of our ZVS inverter technology into stationary, grid-connected applications as we look to accelerate future revenues,” said Hillcrest CEO, Don Currie. “The sheer size of the ESS market represents a phenomenal opportunity for the integration of our technology. Upon successful demonstration and integration of our ZVS inverter prototype, a commercial supply agreement with Ocean Batteries could result in attractive annual sales revenues.”

To view the full press release, visit https://ibn.fm/QZatx

About Hillcrest Energy Technologies Ltd.

Hillcrest is a clean technology company focused on providing advanced power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. Hillcrest is publicly traded on the CSE under the symbol HEAT, on the OTCQB Venture Market as HLRTF and on the Frankfurt Exchange as 7HI. For more information, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) to Deliver Enterprise Upskilling Needs to EGC for Third Year

June 17, 2024 09:47:09

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced that it is extending its partnership with EWIE Group of Companies (“EGC”), a global leader in commodity management services and supply chain optimization with over 30 years of experience. According to the announcement, this is the third year that Amesite will deliver enterprise upskilling needs for EGC’s global teams on EGC’s proprietary Learning Community Environment(R). “Generative AI and other AI tools have changed the game in training,” said Dr. Ann Marie Sastry, CEO of Amesite. “Rather than the same train / test cycle we have seen in play for decades, we are pushing out solutions that offer employees real-time training, on-demand. This shortens training cycles, reduces cost and improves performance. We are excited to expand with companies like EGC.”

To view the full press release, visit https://ibn.fm/7QRYb

About Amesite Inc.

Amesite, an education tech SaaS company, offers its proprietary learning platform and content services to deploy affordable and effective AI for white-labeled online learning programs for colleges and universities. The company’s technology platform leverages cutting-edge AI to offer an innovative out-of-the box, AI-powered learning ecosystem, complete with 24/7 learner support, up-to-date content and ready-to-go programs to quickly deploy and generate revenue. With the announcement of NurseMagic(TM), Amesite has entered the B2C AI app market. Amesite has also announced other apps being developed on its infrastructure, including a public safety app that includes training and preparedness for active shooter response. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participates in EULAR 2024 with Tonmya(TM) Poster Presentation

June 17, 2024 07:35:00

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, participated in this month’s Annual European Congress of Rheumatology (“EULAR”) event. The gathering was held June 12–15, 2024, in Vienna, Austria. According to the announcement, the company presented a poster during the four-day international event. According to the announcement, the poster indicated that treatment with Tonix’s Tonmya(TM) (TNX-102 SL, sublingual cyclobenzaprine HCl) in a phase 3 RESILIENT study resulted in significantly reduced daily pain while also showing broad fibromyalgia symptom improvement.

“People suffering with fibromyalgia tend to struggle with daily activities, have impaired quality of life and are frequently disabled,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release. “We believe the activity of Tonmya on pain, sleep quality, fatigue cognitive dysfunction and depression are indicative of the broad-spectrum activity of Tonmya, suggesting Tonmya treats fibromyalgia at a syndromal level. We are excited by the prospect of offering this patient population its potential first new therapy option in more than a decade.”

To view the poster, visit https://ibn.fm/6r02J

To view the full press release, visit https://ibn.fm/UV4ds

About Tonix Pharmaceuticals Holding Corp.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Spire Global, Inc. (NYSE: SPIR) Featured in Coverage of ROTH’s 10th Annual Roth London Conference

June 14, 2024

June 14, 2024 13:41:46

Spire Global (NYSE: SPIR) is a global provider of space-based data, analytics and space services, offering unique datasets and powerful insights about Earth so that organizations can make decisions with confidence in a rapidly changing world. Spire builds, owns, and operates a fully deployed satellite constellation that observes the Earth in real time using radio frequency technology. The data acquired by Spire’s satellites provides global weather intelligence, ship and plane movements, and spoofing and jamming detection to better predict how their patterns impact economies, global security, business operations and the environment. Spire also offers Space as a Service solutions that empower customers to leverage its established infrastructure to put their business in space. Spire has nine offices across the U.S., Canada, UK, Luxembourg, Germany and Singapore. For more information, visit the company’s website at www.spire.com.

Benjamin Hackman
Head of Investor Relations
Benjam i [email protected]

Kristina Spychalski
Head of Communications
[email protected]

To schedule a one-on-one meeting, please contact your ROTH representative.

To view IBN’s coverage of the event, visit https://ibn.fm/RothLondon2024

About IBN’s Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

InvestorNewsBreaks – Kidpik Corp. (NASDAQ: PIK) Announces $2M Private Placement

June 14, 2024

June 14, 2024 09:36:55

Kidpik (NASDAQ: PIK), a children’s clothing subscription box company, has entered into a securities purchase agreement (“SPA”) with EF Hutton YA Fund LP. According to information filed with the U.S. Securities and Exchange Commission (“SEC”), the agreement calls for Kidpik to sell three tranches of convertible debentures totaling an aggregate principal amount of $2 million. The first tranche, valued at $500,000 was completed on May 18, 2023. Kidpik also agreed to sell an additional $500,000 in convertible debentures upon the filing of a definitive proxy statement with the SEC seeking stockholder approval for, among other things, a merger with Nina Footwear Corp. The SEC filing notes that the company also agreed to sell a third tranche and third convertible debenture of $1 million on or about the date the initial registration statement becomes effective and the approval of its stockholders has been obtained.

To view more information, visit https://ibn.fm/cPmTk and https://ibn.fm/epWOq

About KidPik Corp.

Kidpik was founded in 2016 as an online clothing subscription box for kids, offering mix-and-match, expertly styled outfits that are curated based on each member’s style preferences. Kidpik delivers a surprise box monthly or seasonally, providing an effortless shopping experience for parents and a fun discovery for kids. Each seasonal collection is designed in-house by a team with decades of experience designing children’s wear. Kidpik combines the expertise of fashion stylists with proprietary data and technology to translate kids’ unique style preferences into surprise boxes of curated outfits. The company has announced its pending merger with Nina Footwear Corp. For more information about the company, please visit www.Kidpik.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New Client Contract for Security Robot, Existing Client Purchase of Additional Blue Light Tower

June 13, 2024 12:56:37

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has entered a contract with a top-50 U.S. bank. According to the announcement, the agreement calls for the deployment of Knightscope’s K5 Autonomous Security Robots (“ASR”) with the first deployment slated for one of the bank’s locations in Kansas City.

KSCP’s ASRs will enable the new client “to create a place where team members can grow and thrive, while making a positive impact on the communities they serve,” said the company in the press release. “To achieve this, they commit to ongoing investments in programs and products that serve its customers, support a healthy working environment for their team members and strengthen the communities of its 275 branch and ATM locations.

Knightscope’s innovative K5, a fully autonomous outdoor robot, can provide constant surveillance of a given area. “The robot’s commanding size along with its conspicuous lighting, strobe lights, broadcast messages and patrol sounds, effectively deter illicit activities, while its sensors gather evidentiary-quality video and publicly available data to aid investigations,” said the company in the press release.

In addition, Knightscope announced that the University of Texas (“UT”) has purchased another Knightscope K1 Blue Light Tower; the device will be installed in Tyler, Texas, at a satellite campus. The blue illuminated towers operate 24/7/365 and provide a way to report precise locations when emergency services are required.

“UT has embraced the technology to help provide an enjoyable environment for students, faculty and visitors by making reliable, one-touch access to services such as police, fire and EMS available to everyone on campus,” said the company in the press release.

To view the full press release, visit https://ibn.fm/i7hgq

About Knightscope, Inc.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Signs Option Agreement with USC to Exclusively Evaluate Novel Technology for Commercialization

June 13, 2024 12:44:09

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has entered into an exclusive option agreement with the University of Southern California (“USC”). Signed June 11, 2024, the option agreement allows FSD Pharma to exclusively evaluate, for an initial term of six months, a novel dietary supplement technology for commercialization. At the end of this term, the company will have the option to either extend it for a further six months or to sign an exclusive license with USC for the technology. The company is evaluating this novel technology for the potential to further increase the effectiveness of certain ingredients currently present in unbuzzd(TM). Launching this summer, unbuzzd(TM) is a scientifically formulated blend of vitamins, minerals, and herbs. It is engineered to increase alcohol metabolism, enable faster recovery from alcohol consumption, and simultaneously improve mental alertness. “We are thrilled to sign the option agreement with USC. We are looking forward to evaluating this novel technology that has the potential to both further enhance the effectiveness of unbuzzd(TM) and increase our target market by enabling the development of new products,” said Zeeshan Saeed, Founder, CEO and Executive Co-Chairman at FSD Pharma, in the press release.

To view the full press release, visit https://ibn.fm/gcrdJ

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly “Lucid-21-302”). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD has also licensed unbuzzed(TM), a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. (“Celly Nu”) and is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. FSD continues its R&D activities to develop novel formulations for alcohol misuse disorders and continues the development of such treatments for use in the healthcare sector. FSD maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information, visit the company’s website at www.FSDPharma.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) Partners to Expand Footprint in Colorado

June 13, 2024 12:32:40

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced that it has secured comprehensive distribution coverage for its brands throughout Colorado. The company has achieved this significant milestone through a new statewide distribution agreement with Legacy Distribution Group, experts in transforming brands into household names within Colorado. Under the new relationship, Legacy Distribution Group will distribute Splash’s diverse portfolio including Copa di Vino, Pulpoloco and SALT Tequila to retailers and on-premise operators across the state. The announcement noted that with Legacy Distribution Group’s expansive network and market expertise, Splash is well positioned to significantly increase its market presence and consumer base in Colorado. “We are thrilled to partner with Legacy Distribution Group,” said Robert Nistico, CEO of Splash. “Their impressive track record, full state coverage and deep market penetration make them the perfect partner to help us expand our footprint in Colorado. A strong distribution network is crucial to the long-term success of our business. It is through this network that we can reach retailers and ultimately, the end consumer to enjoy our fabulous products.”

To view the full press release, visit https://ibn.fm/AET2Q

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT flavored tequilas, Pulpoloco sangrías, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) Shares Operational Update

June 13, 2024 12:17:28

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that provides proprietary motor-control and complete electric propulsion system technology for e-mobility, today provided an operational update. The update covered the company’s propulsion system deliveries, progress with partners, and the signing of its first-ever outbound intellectual property licensing agreement with Capri, Italy-based Tier-1 OEM supplier HB4. More specifically, the update noted that Exro produced 46 propulsion systems for customers in April and May and is focused on meeting its goal of delivering over 250 propulsion systems to customers through Q2 and Q3 of 2024. It further highlighted the company’s continued progress with deliveries to its blue-chip OEM and Tier 1 customers like Hino Trucks and Mack Trucks, partnerships with Giaffone Electric and Linamar Corporation, and the innovation program with its leading global NDA passenger vehicle partner, which continues on track through phase 2. Additionally, the update noted the conclusion of the testing program necessary for UL certification of its Cell Driver(TM) stationary energy storage system. Exro anticipates certification in June. “As promised, since the closing of the acquisition of SEA Electric on April 5, Exro has been focused on increasing revenue, reducing costs, and progressing technology development,” said Exro CEO Sue Ozdemir. “Since our last update three weeks ago, there has been progress across these three facets. The past 60 days have provided many challenges, opportunities, and progress, with management working diligently to implement process that helps to scale the business efficiently and profitably. We are focused on our execution with customers while continuing to utilize our technology to break down the barriers to electrification including cost, performance, and infrastructure.”

To view the full press release, visit https://ibn.fm/kErB3

About Exro Technologies Inc.

Exro Technologies is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM)), and act to accelerate adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) Meridianbet Launches New Product Extending Commitment to Providing Unparalleled Gaming Experience

June 13, 2024 11:30:00

Golden Matrix Group’s (NASDAQ: GMGI) subsidiary Meridianbet, a prominent global iGaming and sports betting operator, today announced the launch of its new Casino Bonus Wallet. The new Casino Wallet exclusively holds casino bonus funds that players receive by participating in active promotions on Meridianbet’s site. Players can use the bonus funds to play all games in the slots offering. The Casino Bonus Wallet’s key features include automated rollover, which transfers the bonus system across various products; customizable rollovers, which give players the option to set different rollover requirements for various types of games; live progress bar, which allows players to track their bonus progress in real-time; diverse game selection, which caters to a wide range of player preferences by allowing for the selection of different games, categories, and providers for promotion; and transparent gameplay, which ensures players know exactly which games can be played with bonus money. The announcement noted that Meridianbet’s introduction of the Casino Bonus Wallet is a testament to its ongoing innovation and commitment to providing an unparalleled gaming experience. It underscores Meridianbet’s dedication to solidifying its position in Europe’s online casino (iGaming) community.

To view the full press release, visit https://ibn.fm/xiZQj

About Golden Matrix Group Inc.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Reconfirms Position as America’s Leading ISR Uranium Company with New TRS Filing

June 13, 2024 10:32:41

Uranium Energy (NYSE American: UEC), the fastest growing supplier of the fuel for the green energy transition to a low carbon future, has filed a new S-K 1300 technical report summary (“TRS”) on EDGAR. The TRS discloses updated mineral resources for the company’s Texas Hub and Spoke ISR platform with an increase in resources at the Burke Hollow Project. According to the announcement, the new TRS increases the Burke Hollow Project’s Measured and Indicated (“M&I”) resources from 2,324,000 lbs U 3 O 8 to 6,155,000 lbs and Inferred resources of 4,883,000 lbs U 3 O 8. Total Texas Hun and Spoke platform’s disclosed M&I resources are now 12,958,000 lbs, with 7,241,000 tons grading approximately 0.085% U 3 O 8, and Inferred resources are now 9,948,100 lbs, with 4,356,000 tons grading approximately 0.120% U 3 O 8. The announcement noted that this latest S-K 1300 TRS reconfirms UEC’s position as America’s leading ISR uranium company, with its South Texas and Wyoming Hub and Spoke platforms having 79,156,000 lbs U 3 O 8 of M&I resources and 25,002,000 lbs of Inferred resources. “Since the initial discovery at Burke Hollow, we’ve continued to increase resources with every drilling campaign and update. We have identified several mineralized trends and horizons for potential resource growth and nearly half of the ~20,000 acre Burke Hollow property remains under-explored. Burke Hollow is the largest ISR uranium discovery in the United States in the past decade and will be an exciting satellite project as part of our hub-and-spoke strategy,” said Andy Kurrus, UEC V.P. of Resource Development, Texas.

To view the full press release, visit https://ibn.fm/RaCog

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American focused uranium company, advancing the next generation of low-cost, environmentally friendly In-Situ Recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming. These platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – FE Battery Metals Corp. (CSE: FE) (OTC: FEMFF) Report Positive Lab Results from Augustus Lithium Project Testwork

June 13, 2024 09:01:23

FE Battery Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, is reporting the positive results of hydrometallurgical testwork at its Augustus Lithium Project. According to the announcement, the testing produced battery-grade lithium carbonate from pegmatite samples obtained from the project, which is adjacent to the North American Lithium mine in Quebec. FE Battery Metal worked with SGS Canada Inc. for the testwork, which evaluated, established and confirmed the optimal hydrometallurgical process flowsheet required to successfully extract high-purity lithium carbonate from previously developed spodumene concentrate produced from the Augustus Lithium Project. The world’s leading testing, inspection and certification company, SGS is widely recognized as establishing the global benchmark for sustainability, quality and integrity; the company has 99,600 employees and 2,600 offices and laboratories around the world. “SGS was pleased to support our client, FE Battery Metals Corp, in developing a hydrometallurgical flowsheet for extracting high-purity lithium carbonate, a crucial chemical in the battery supply chain,” said SGS North America vice president of natural resources Cordoba in the press release. “Our Lakefield team is committed to delivering innovation in extractive metallurgy while upholding our company’s strong commitment to sustainability.”

FE also announced the acquisition of 47 mineral claims in two claim blocks covering approximately 2,759.80 hectares of land in Québec. The company acquired the mining claims from an arm’s length seller. The company noted that infrastructure support, availability of water and power locally, and historically successful results make the claims a promising exploration target for rare earth metals and uranium.

To view the full press release, visit https://ibn.fm/ZDlaZ

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. The company’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FEBatteryMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Embracing Patient-Centric Healthcare: The 4th Chief Patient Officer Summit

June 13, 2024 08:50:00

The upcoming 4th Chief Patient Officer Summit, hosted by Dynamic Global Events, will convene on July 15-16, 2024, in Boston, MA. Professionals in Patient Affairs, Clinical Trials, Patient Communications, Patient Advocacy, and related industry areas are invited to attend at the Hilton Boston Back Bay.

The summit, which will include panel presentations, two concurrent workshops, and networking opportunities, will gather top leaders from the healthcare industry to focus on patient engagement and…

For conference and registration details, visit www.dgevents.com/event/chief-patient-officer-summit/

*Use discount code IBN2024 to save 15% off*

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Maritime Launch Services (OTCQB: MAXQF) (Cboe CA: MAXQ) Featured in Article Covering Canada’s Recent Multimillion-Dollar Deal to Backstop Construction of a New Spaceport

June 12, 2024 13:02:06

In a landmark move signaling Canada’s firm commitment to space exploration, the government has thrown its support behind what is being called Canada’s version of Cape Canaveral. This endorsement comes at a time when the global demand for commercial space launches is reaching unprecedented levels. The Rude Awakening, a division of Paradigm Press headed up by former banker and financial educator Sean Ring, recently published an article titled “King: Canada’s Cape Canaveral North” that covers the momentum taking place in the space sector.

As pointed out by the article’s author Byron King, the decision to support investment in the construction of a spaceport underscores the Canadian government’s recognition of the economic and technological potential of the space sector. The Government of Canada is clearly keen to become a leading player in the rapidly evolving space industry, fostering innovation, job creation and international collaboration.

A notable development in this ambitious project is the involvement of Maritime Launch Services Ltd. (OTCQB: MAXQF), a Canadian-owned commercial space company based in Nova Scotia. The company recently entered an agreement with the Province of Nova Scotia and the Government of Canada that extends generous terms to reimburse the costs for various launch facilities.

The demand for commercial launch services has surged in recent years, driven by the proliferation of satellite technologies, the rise of private space companies and the increasing accessibility of space exploration. The Maritime Launch location, Spaceport Nova Scotia, offers unparalleled advantages for meeting this demand, with access to polar and sun synchronous orbits and minimal air and maritime traffic ensuring efficient and cost-effective access to space.

As the global space industry continues to evolve, Canada stands poised to play a central role in shaping its future. With the Canadian and provincial government’s support, coupled with the demand for commercial launch services and its strategic location, the construction of a new spaceport represents a bold step forward for Canada’s program and a testament to the nation’s commitment to commercial space and innovation.

To view the full article, visit https://ibn.fm/8FAZJ

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Plutonian Acquisition Corp. (NASDAQ: PLTN), Big Tree Cloud Holdings Limited (NASDAQ: DSY) Complete Business Combination

June 12, 2024 12:51:39

EF Hutton has announced that it served as the sole underwriter to Plutonian (NASDAQ: PLTN), a special purpose acquisition company, in connection with its approximately $500 million completed business combination with Big Tree Cloud International Group Limited, a consumer-oriented company dedicated to the development, production and sales of personal care products and other consumer goods in China. The listed company following the business combination is Big Tree Cloud Holdings Limited (NASDAQ: DSY, DSYWW), and its shares and warrants have commenced trading on the Nasdaq under the tickers DSY and DSYWW, respectively.

For more information regarding the transaction, visit https://ibn.fm/RKsWb

About Plutonian Acquisition Corp.

Plutonian is a Delaware corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Collaborates to Open Gold Circulation Channels

June 12, 2024 09:26:53

Blue Hat (NASDAQ: BHAT) and Sichuan Jinyinghe Industrial Co. Ltd. announced the signing of a framework cooperation agreement to jointly establish a leading gold supply chain company. According to the announcement, the collaboration aims to integrate industrial resources and international financial capital to address various issues currently faced by the gold industry, promote transformation and innovation, and create a comprehensive, efficient gold supply chain ecosystem. “Collaborating with Jinyinghe, a company with many years of experience in gold trading and supply chain management, is another significant step following our acquisition of a Class A license as a precious metals and gemstone dealer from Hong Kong Customs,” said Blue Hat CEO Chen Xiaodong. “We will introduce international resources and work with Jinyinghe to open up gold circulation channels in relevant countries and regions, including but not limited to Southeast Asia and the Middle East. The successful operation of this project will enhance Blue Hat’s operational strength and market influence and provide an excellent platform and opportunity for participants in the gold business, effectively promoting the transformation of the gold industry.”

To view the full press release, visit https://ibn.fm/VyvgI

About Blue Hat Interactive Entertainment Technology

Blue Hat was formerly a provider of communication services and IDC business, as well as a producer, developer and operator of AR interactive entertainment games, toys and educational materials in China. Leveraging years of technological accumulation and unique patented technology, Blue Hat is expanding its business to commodity trading, aiming to become a leading intelligent commodity trader worldwide. For more information, please visit the company’s investor relations website at http://ir.bluehatgroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Strategic Alliance, Private Equity Investment

June 12, 2024 09:14:41

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) in adults). The company today announced the execution of a strategic marketing and distribution alliance with an operator of multiple sleep testing and treatment centers in Colorado. Hoped to be the first in a series across the country, the alliance marks an important pivot in Vivos’ marketing and distribution model for its cutting edge OSA appliances. “We cannot overstate the importance of this alliance to Vivos and its future, coupled with a validating private equity-led investment from Seneca,” said Kirk Huntsman, chairman and CEO of Vivos. “Over the last several years, peer-reviewed studies have confirmed our longstanding belief that Vivos has the most effective, safe and potentially lasting non-surgical solution for all severities of OSA in adults that does not require lifelong nightly intervention. This was further validated by recent unprecedented FDA clearances Vivos has received, including the only FDA clearance for an oral medical device to treat severe OSA in adults.”

To view the full press release, visit https://ibn.fm/OFXn2

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to severe OSA in adults. It has proven effective in over 42,600 patients treated worldwide by more than 1,950 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary CARE appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The three Vivos CARE devices open airway space and may significantly reduce symptoms and conditions associated with mild to severe OSA in adults, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The Sustain SoCal Driving Mobility 11 Expo and Symposium

June 12, 2024 08:50:00

Sustain SoCal invites state and regional leaders to discuss mobility policy, efforts towards EV charging infrastructure, incentives to go electric, cybersecurity considerations, V2X, hydrogen/fuel cell, investor trends, legislative updates, and other green modes of transport at Driving Mobility 11 on June 27th, 2024 in Irvine, CA.

Enjoy a discussion on best practices and new solutions followed by a clean…

To know more, please visit https://ibn.fm/yKMfu

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Enters Million-Dollar Share Exchange Agreement with Horizon Fintex

June 11, 2024 14:05:25

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, buying, investing and growing an innovative portfolio of companies and attaching digital securities to those businesses, has entered into a $3.75 million share exchange agreement with GlobexUS Holdings Corp. (Horizon Fintex). Horizon Fintex is the pioneering force powering the regulated tokenized-securities exchange Upstream. According to the agreement, Horizon Fintex issued 1,250 common shares, priced at $3,000 per share, in exchange for one million newly issued common shares in Diamond Lake Minerals. The share exchange partnership will benefit both parties by bringing new issuers to list on Upstream and increasing Upstream’s trading liquidity while also providing economic benefit to each company’s shareholders. In addition, Diamond Lake Minerals entered into a Cooperation, Marketing & Referral Agreement with a Horizon Fintex subsidiary as a commercial advisor to introduce and refer issuers seeking to list on Upstream. “When I took over DLMI in August of 2023, we set out to build what we believe will be the model of all future public companies, and I knew we could not accomplish that without international partners that know and understand securities laws, rules and regulations, and how we can properly and legally accomplish what we set out to do in the current regulatory frameworks,” said Diamond Lake Minerals CEO Brian J. Esposito in the press release. “We found all of that in Horizon Fintex, along with an impressive suite of blockchain technologies, and this partnership is yet another major milestone in the DLMI journey as we continue to build this great company, and strongly execute on our vision and plans.”

To view the full press release, visit https://ibn.fm/poCS6

About Diamond Lake Minerals Inc.

Diamond Lake Minerals was founded in 1954 and is a multistrategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens. The company’s goal is to responsibly innovate and develop valuable traditional businesses and successfully combine those businesses with the future of money and digital assets. DLMI’s mission is to bring back to the public markets timeless business principles that are focused on healthy sustainable growth and strong earnings that generate yields combined in a modern digital world creating value for company stakeholders. DLMI is positioning itself as an industry agnostic leader in the digital asset and security token space. For more information, visit the company’s website at www.DiamondLakeMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial

June 11, 2024 13:49:44

Processa (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial. The trial defined the maximum tolerated dose (“MTD”) and recommended Phase 2 dose range (“RP2DR”) for Next Generation Capecitabine (“NGC-Cap”) administered to patients with stage III or IV gastrointestinal tract (“GI”) cancer. “We are encouraged by the preliminary efficacy analysis from our NGC-Cap Phase 1b dose-escalating safety/tolerability trial demonstrating some anti-tumor activity in patients with advanced GI cancer who have progressive cancer after relapsing or not responding to prior therapy. The favorable response is likely due to NGC-Cap’s ability to distribute more 5-FU to cancer cells than monotherapy capecitabine. The promising Phase 1b safety and tolerability profile plus these early efficacy signals provide validation for further development of NGC-Cap,” said David Young, PharmD, Ph.D., president of research and development at Processa. “From this Phase 1b trial, we have been able to define the MTD and the RP2DR to use in our Phase 2 Optimal Dosage Regimen trial in breast cancer in the third quarter of 2024.”

To view the full press release, visit https://ibn.fm/yp48Q

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the Next Generation Chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining its novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach, as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will provide better therapy options to cancer patients but will also increase the probability of FDA approval for its NGC drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. The Processa team has a track record of obtaining over 30 indication approvals across almost every division of the FDA. Using its proven Regulatory Science Approach, the Processa Team has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGCs are expected to include fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response and a greater number of patients – in excess of 200,000 for each NGC drug – who will benefit from each NGC drug. Processa is currently 1) starting to initiate sites for the Phase 2 study that will identify the optimal dosage regimen for Next Generation Capecitabine (“PCS6422” and capecitabine to treat breast, metastatic colorectal, gastrointestinal, pancreatic and other cancers), 2) defining the design of the Next Generation Gemcitabine (“PCS3117” to treat pancreatic, biliary, lung, ovarian, breast and other cancers) Phase 2 optimal dosage regimen study to discuss with FDA, and 3) defining the formulation and toxicology program for Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities

June 11, 2024 13:30:31

Predictive Oncology (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a key role in tumorigenesis, with prior studies demonstrating involvement in cancer initiation, progression and metastasis. “As a result of our sustained efforts to develop this technology, Predictive Oncology has been able to file expansive intellectual property (‘IP’) protection for its novel GPCR expression platform,” said Dr. Larry DeLucas, SVP of biologics for Predictive Oncology. “We believe that this technology will open significant partnering opportunities for our company, and we look forward to working with drug discovery and development companies that are targeting GPCRs to expand their portfolios and replenish their pipelines.”

To view the full press release, visit https://ibn.fm/EX6GW

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. Predictive Oncology is headquartered in Pittsburgh, Pennsylvania.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar

June 11, 2024 13:13:28

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options. The company today announced its appointment of Dr. Atul R. Mahableshwarkar M.D., DLFAPA, as its senior vice president, clinical development. Dr. Mahableshwarkar will lead the development of the CYB003 program, Cybin’s proprietary deuterated psilocybin analog that has received FDA Breakthrough Therapy Designation for the adjunctive treatment of major depressive disorder. “We are delighted to welcome Dr. Mahableshwarkar to the Cybin team at this critical juncture in the company’s progression,” said Amir Inamdar, chief medical officer of Cybin. “As we approach the initiation of our phase 3 study of CYB003, Dr. Mahableshwarkar’s deep experience of successfully running global phase 3 programs will be invaluable. His broad expertise across strategic, developmental and regulatory domains will no doubt contribute to accelerating Cybin’s path forward.”

To view the full press release, visit https://ibn.fm/83b5y

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – SenesTech Inc. (NASDAQ: SNES) to Present at Emerging Growth Conference

June 11, 2024 12:27:47

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is scheduled to present at the 72nd Emerging Growth Conference, hosted by leading independent small cap media portal EmergingGrowth.com. Taking place on June 12 – 13, 2024, the event identifies companies in a wide range of growth sectors with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long-term growth. Joel L. Fruendt, president, CEO and director of SenesTech is scheduled to provide a keynote speech at the conference starting at 3:20 p.m. ET on June 12.

To view the full press release, visit https://ibn.fm/RTAKN

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Commercial Production of ‘On-Spec’ NdPr

June 10, 2024 14:16:02

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (“REEs”) and vanadium, today announced that it has achieved commercial production of separated neodymium-praseodymium (“NdPr”) at its White Mesa Mill in Utah. According to the announcement, the NdPr produced by Energy Fuels meets applicable product specifications of REE metal makers who specialize in the manufacture of REE-based alloys required for the permanent magnets widely used for electric motors in both battery powered electric vehicles (“EVs”) and dual power hybrids. Further, Energy Fuels is now able to produce this “on-spec” NdPr at the full design capacity of its new phase 1 REE separation circuit (850 to 1,000 metric tons “tonnes” of NdPr per year). The company expects to have commercial quantities of separated NdPr available for shipment by the end of this month. Energy Fuels believes this is the first time in several decades that a U.S. company has produced on-spec separated REE from monazite on a commercial scale.

To view the full press release, visit https://ibn.fm/rpEXq

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium and critical minerals company. The company, as a leading producer of uranium in the United States, mines uranium and produces natural uranium concentrates that are sold to major nuclear utilities for the production of carbon-free nuclear energy. Energy Fuels recently began production of advanced rare earth element (“REE”) materials, including mixed REE carbonate in 2021, and commenced production of commercial quantities of separated REEs in 2024. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is evaluating the recovery of radionuclides needed for emerging cancer treatments. Its corporate offices are in Lakewood, Colorado, near Denver, and substantially all its assets and employees are in the United States. Energy Fuels holds two of America’s key uranium production centers: the White Mesa Mill in Utah and the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant, as well as REE products, from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The company recently acquired the Bahia Project in Brazil and entered into a joint venture agreement to develop the Donald Project in Australia , each of which is believed to have significant quantities of titanium (ilmenite and rutile), zirconium (zircon) and REE (monazite) minerals. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects in production, on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU, and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Dalmore Group Exec Featured Guest in Latest Episode of The Bell2Bell Podcast

June 10, 2024 12:37:42

Dalmore Group, a tech-driven investment bank and broker dealer on a mission to revolutionize the way companies raise capital online, is spotlighted in the most recent episode of The Bell2Bell Podcast. Released by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, the Bell2Bell Podcast delivers exclusive interviews with executives and professionals operating in fast-moving industries. During the podcast, Dalmore Group director of sales Stormer Santana and host Jonathan Keim discussed what Santana enjoys most about working in online fundraising, which is the opportunity to interact with hundreds of passionate entrepreneurs. Santana also explained how companies raise capital online in the current environment, which started through the JOBS Act, which introduced Regulation Crowdfunding (Reg CF), Regulation A+ and Regulation D. Typically, the general population doesn’t have access to private investment opportunities, Santana observed, but now issuers are leveraging these tools to reach out “the masses, raise capital in volume from the crowd and really bring on a sense of community.” Santana also noted that Reg A+, which allows an entity to raise up to $75 million in capital, is Dalmore’s focus. “We’ve been fortunate enough to participate with some of the really significant offerings in the U.S. and over 50% of all Reg A+ filings, per KingsCrowd,” said Dalmore Group director of sales Stormer Santana in the press release. “Finally, there’s Reg D, which is reserved for accredited investors only. Of course, that’s a very popular and common path to raise capital. Some of our issuers are leveraging CF, A+ and D concurrently in different strategies. At a high level, those are some of the exemptions that we’re focused on and how issuers are leveraging them.”

To listen to the full episode, visit https://ibn.fm/eZPJN

To view the full press release, visit https://ibn.fm/UJ5vW

About Dalmore Group

Dalmore is a tech-driven, FINRA-registered, full-service, broker-dealer on a mission to revolutionize the way companies raise capital online. With its focus on relationships and results, Dalmore is a people-driven firm. Dalmore prides itself on hiring and teaming with professionals that bring integrity, quality and professionalism to its organization so that, through teamwork and a common vision, Dalmore can best serve its clients. For more information, visit the company’s website at www.DalmoreGroup.com

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI Holdings Inc. (ECGI) Executing Strategic Plan to Create Firmer Foundation for Pursuing New Ventures, Growth

June 10, 2024 10:20:00

ECGI is implementing several prudent measures to create a stronger foundation for pursuing new strategic ventures and growth opportunities
The company recently announced an agreement to convert $2 million of debt into equity, with conversion expected to be completed during Q4 of its fiscal year
ECGI has previously announced the reduction of over $1.5 million in liabilities, a reduction of over $350,000 in convertible notes payable and accrued interest, and an improvement in total stockholders’ deficit totaling over $1 million
The company is determined to position itself to aggressively identify and capitalize on growth opportunities that align with its business objectives

ECGI Holdings (OTC: ECGI), a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion, recently announced an agreement to convert $2 million of debt into equity. The agreement, anchored in section 3(a)(10) of the Securities Act of 1933, is a significant milestone in the company’s ongoing efforts to enhance financial stability in pursuit of significant market opportunities. The debt-to-equity conversion is set to be completed during the ECGI’s fiscal fourth quarter, ending August 31, 2024 (https://ibn.fm/kTWFt).

The 3(a)(10) debt-to-equity conversion is to strengthen the company’s balance sheet, alleviating a significant portion of its financial obligations, and allowing it to redirect its resources toward growth and innovation. During the first two quarters of fiscal 2024, ECGI implemented a number of strategies to reduce the strain of past debts.

The company recently reported successfully identifying and reducing over $1.5 million in accounts payable and accrued liabilities. ECGI heralded this achievement as a testament to its ongoing commitment to operational efficiency and fiscal responsibility. With the significant reduction in its liabilities and the ongoing cleanup of its balance sheet, a March 2024 news release said, the company anticipates a notably positive effect on its share structure.

In addition, ECGI identified and implemented the reduction of more than $350,000 in convertible notes payable and accrued. The company also reported an improvement in the total stockholders’ deficit, amounting to over $1 million. ECGI believes these recent measures to reduce liabilities will contribute significantly to long-term shareholder value as well as the company’s overall economic vitality.

“By reducing the strain of past debts, we are creating a firmer foundation for pursuing new strategic ventures and growth opportunities,” ECGI said in its news release announcing the debt-to-equity conversion. “We expect these financial maneuvers to bolster investor confidence and attract further investments, enhancing shareholder value and solidifying our market position.”

ECGI’s extended commitment to financial health, intended to help unlock future growth potential, is supported operationally by its ongoing focus on growth opportunities that align with its business opportunities. This focus has led to the company investing in Pacific Saddlery, Inc., a premier manufacturer and retailer of luxury products and services. Pacific Saddlery debuted a new mobile retail boutique at the prestigious Desert International Horse Park’s Desert Circuit event earlier this year. The mobile boutique concept enabled ECGI and Pacific Saddlery to take their luxury equestrian products closer to professionals and enthusiasts.

In addition to its strategic investment in Pacific Saddlery, ECGI owns and manages a five-acre vineyard in Lake County, California. The vineyard specializes in the cultivation of Petite Sirah, a variety of grapes famed for its bold and rich character. Besides aligning with the growing demand for unique and high-quality wine experiences, the vineyard enables ECGI to tap into the U.S. wine market, expected to grow from $60.1 billion in 2024 to $73.4 billion by 2028, according to Statista (https://ibn.fm/rA0a1).

ECGI is also eyeing the U.S. segment of the global short-term rental market. The global market is projected to grow at a CAGR of 10.87% from 2024 to 2033, reaching $315.18 billion by the end of the forecast period from $112.31 billion in 2023 (https://ibn.fm/bI0hr). To capitalize on this expected growth, ECGI is transforming its 40-acre Lake County, California, property into a luxurious short-term rental destination known as Vintner’s Caldera Ranch. The program was launched in early May (https://ibn.fm/mp9vO), and includes exposure in Airbnb, Vrbo, and Bookings.com. Evolve will continue to leverage its expertise in maximizing rental potential and delivering exceptional guest experiences to ensure that Vintner’s Caldera Ranch exceeds the high standards of service and luxury that guests expect.

For more information, visit the company’s website at www.ECGIHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Participate in Upcoming Emerging Growth Virtual Conference